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Abstract 
The long established tradition of yogurt consumption has been related to longevity of 
some populations living on the Balkans. Yogurt starter L. delbrueckii subsp. bulgaricus 
and Str. thermophilus have recently been recognized as probiotics with verified beneficial 
health effects. The oral cavity emerges as a relevant target for probiotic applications and 
probiotics have demonstrated promising results in controlling dental diseases and yeast 
infections. However, L. delbrueckii subsp. bulgaricus despite its broad availability in 
fermented dairy products has not been evaluated for possible probiotic activity in the 
mouth. 
These series of studies were conducted to investigate in vitro properties of L. 
delbrueckii subsp. bulgaricus to outline its potential as an oral probiotic. Prerequisite 
probiotic properties in the oral cavity are resistance to oral defense mechanisms, 
adherence to saliva-coated surfaces, and inhibition of oral pathogens. L. delbrueckii subsp. 
bulgaricus strains  showed  a  strain-dependent  inhibition  of  oral  streptococci  and  
Aggregatibacter actinomycetemcomitans,  whereas  none  of  the  dairy  starter  strains  could  
affect growth of Porphyromonas gingivalis and Fusobacterium nucleatum. 
Adhesion to surfaces is a factor contributing to prolonged establishment of the species 
at the target site. Fifteen radiolabeled dairy L. delbrueckii subsp. bulgaricus strains and L. 
rhamnosus GG were tested for their ability to adhere to saliva-coated hydroxyapatite 
beads  and  polystyrene  microtiter  plates.  The  effects  of  lysozyme  on  the  adhesion  of  
lactobacilli and of the pretreatment with lactobacilli on the adhesion of Streptococcus 
sanguinis were also assessed. The adhesion of the L. delbrueckii subsp. bulgaricus strains 
remained lower in comparison to L. rhamnosus GG. One L. delbrueckii subsp. bulgaricus 
strain showed binding frequency comparable to S. sanguinis.  Lysozyme  pretreatment  of  
the samples significantly increased Lactobacillus adhesion to saliva-coated surfaces. 
Insubstantially low gelatinolytic activity was observed in the supernatant and cell 
fractions of all strains supernatant specimens being slightly more proteolytic, and no 
conversion of proMMP-9 to its active form was induced by L. delbrueckii subsp. 
bulgaricus. Safety assessment ruled out deleterious effects of L. delbrueckii subsp. 
bulgaricus on extracellular matrix structures. 
Cytokine response of oral epithelial cells after L. delbrueckii subsp. bulgaricus 
challenge was assessed by measuring IL-8 and TNF-? levels in cell culture supernatants. 
The effect of Porphyromonas gingivalis on cytokine secretion after lactobacilli 
pretreatment was also assessed. A strain- and time-dependent induction of IL-8 was 
observed with live bacteria inducing the highest levels of cytokine secretion. Generally, 
levels of TNF-? were low and only one of ten L. delbrueckii subsp. bulgaricus strains 
stimulated  TNF-? secretion  closely  to  that  of  the  positive  control.  The  addition  of  P. 
gingivalis produced almost an immediate reduction of cytokine levels within the first 
hours of incubation irrespective of lactobacilli strains co-cultured with epithelial cells. 
According  to  this  series  of  studies  there  are  strains  among  the  L. delbrueckii subsp. 
bulgaricus species that may have beneficial probiotic properties in the human oral cavity 
and their potential in prevention and management of common oral infectious diseases to 
be further studied. 
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Abbreviations 
ATCC American type culture collection 
CFU Ccolony forming unit  
DNA       Deoxyribonucleic acid 
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ELISA Enzyme linked immunosorbent assay 
GCF Gingival crevicular fluid 
GIT Gastrointestinal tract 
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HA Hydroxyapatite 
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1 Introduction 
In recent decades, probiotic applications have emerged as a fascinating strategy to 
alleviate symptoms of various diseases, predominantly in the gastrointestinal tract. 
Probiotics are defined as live microorganisms conferring health benefit on the host when 
administered in sufficient amount (www.who.int/foodsafety/fs_management/en/probiotic 
_guidelines.pdf). In humans, the most frequently used probiotics are bacteria from the 
genera Lactobacillus or Bifidobacterium. The list of probiotic species tend to increase and 
new strains to be upended. The efficacy of L. delbrueckii subsp. bulgaricus as a probiotic 
has been questionable due to inconclusive evidence of its establishment and survival in the 
gastrointestinal tract. However, with the accumulation of new data and because of its 
ubiquitous availability in fermented dairy products, the yogurt starter L. delbrueckii subsp. 
bulgaricus was recognized as probiotic when a health benefit was validated in clinical 
trials (Guarner et al., 2005). 
The oral cavity as a gateway to the underlying gastrointestinal tract is the first site of 
contact between probiotics and the host. Despite structural similarities with other parts of 
the digestive system oral cavity is unique for its highly specialized functions and 
characteristic site-specific pathology. The most common oral diseases with great social 
repercussions remain to be dental caries and periodontal disease. The infectious etiology 
of both these pathological conditions is well established and various strategies for control 
of pathogenic oral biofilms are in use.  
The idea that probiotic administration may improve some disease conditions in the 
mouth has recently been introduced and the number of studies published gradually 
increase (Çaglar et al., 2005; Meurman, 2005). Among the probiotics used in the oral 
cavity are species such as L. rhamnosus GG, L. reuteri, L. casei, B. lactis that have shown 
to different extent capacity to reduce mutans streptococci counts or lessen gingival 
inflammation. However, the precise mechanisms explaining the observed effects yet 
remain unclear. 
To comply with the term probiotic several basic requirements should be considered. 
Among these are: 1) safety of the microorganism; 2) conferring health benefits; 3) 
adhesion and colonization capacity; 4) inhibition of pathogens; 5) survival and resistance 
to human defense mechanisms. Additionally, in the scope of the oral cavity, probiotic 
carbohydrate and protein utilization patterns should not expose oral structures to risk of 
disease – such as caries. 
Whenever a new probiotic candidate is evaluated a number of basic in vitro screening 
tests are used. Although in vitro studies have limited ability to completely reproduce 
authentic environmental conditions, they are essential steps in discovery of species that 
may further be used in clinical settings.  
The millennium long tradition of yogurt consumption and the GRAS (generally 
regarded as safe) status  of lactobacilli encouraged us to conduct this series of studies; 
evaluating the L. delbrueckii subsp. bulgaricus strains in its inhibitory capacity against 
common oral pathogens, adherence to saliva-coated surfaces, interaction with oral 
epithelium and above all to test its harmlessness to oral structures. 
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2 Review of the literature 
2.1 Oral cavity in health and disease 
The oral  cavity as an integral  part  of the digestive system has various specific functions.  
Although  it  is  the  entry  and  part  of  the  gastrointestinal  tract  (GIT),  it  possesses  some  
distinctive features that makes it different from the rest of the digestive system. Mouth is a 
unique complex system of tissues and organs that together are involved in nutritional, 
respiratory, and communicative functions. 
Oral health is important for overall health which requires harmonious functioning of 
several key elements in the mouth. The impact of common oral diseases extends beyond 
the oral cavity (Thorstensson and Johansson, 2009). Oral infection has been found to be 
associated with death risk in studies among middle-aged individuals (DeStefano et al., 
1993; Garcia et al., 1998; Soikkonen et al., 2000; Jansson et al., 2002). The relative 
importance  of  oral  health  as  a  predictor  of  survival  has  also  been  analyzed  and  the  
common oral diseases have shown significant influence on survival (Österberg et al., 
1990; Cabrera et al., 2005; Semba et al., 2006; Morita et al., 2006). Therefore, keeping 
oral health unperturbed and well balanced predisposes to long term and stable well being. 
Key elements of oral homeostasis 
Oral mucosa 
The specific structural and functional organization of the epithelial lining of the oral cavity 
serves a key role in oral health maintenance. The oral epithelium provides a physical 
barrier to the outside world. A break in this barrier can easily lead to invasion of harmful 
agents into the body and particularly the exposure of the immune system to various 
microorganisms. Additionally, the human oral mucosa may be considered a first line of 
defence against invading pathogens as the oral cavity is a site where many antigens are 
initially encountered by the body. The role of epithelial cells has been proposed as an early 
warning system or sensor for infection (Eckmann et al., 2000; Aldridge et al., 2005). 
The oral mucosa is anatomically divided into three tissue layers: 1) epithelium; 2) 
basement membrane, and 3) connective tissue. The epithelium consists of approximately 
40-50 layers of stratified squamous epithelial cells. Related to its many functions, the oral 
cavity contains several different types of stratified squamous epithelia, including those 
classified as nonkeratinized, parakeratinized, and orthokeratinized (Brukhardt and 
Maerker, 1981). Primarily nonkeratinized epithelium provides a lining in the cheeks, lips, 
floor of mouth, ventral aspect of the tongue, soft palate, and upper and lower vestibular 
sulci. Parakeratinized and orthokeratinized epithelium lines the hard palate and the mucosa 
surrounding the teeth (Grafström, 2002). The major oral cell types are keratinocytes and 
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gingival epithelial cells (Krisanaprakornkit et al., 2000) that express specific pattern of 
cytokines/chemokines that distinguish them from the epithelium in the gastrointestinal 
tract (Formanek et al., 1999). In addition to the innate barrier function they perform, 
gingival epithelial cells are also capable of expressing two anti-microbial peptides of the 
?-defensin family, human ?-defensin 1 and human ?-defensin 2. The role of ?-defensins 
has been defined in innate host defense against various oral microorganisms 
(Krisanaprakornkit et al., 2000, Devine, 2003, Eberhard et al., 2009; Gardner et al., 2009).  
Tissues of the oral cavity are constantly exposed to innate defenses derived from saliva, 
gingival crevicular fluid (GCF), epithelial cells, and neutrophils, and host-defense peptides 
(HDPs) are significant in all of these, working in synergy with other defense components. 
Saliva 
Saliva effectively mediates the fine coordination of various functions of the oral cavity 
and plays an important role in the maintenance of the overall health. Whole saliva is a 
complex mixture of parotid, submandibular, sublingual and minor salivary gland 
secretions mixed with bacteria, leukocytes, desquamated epithelial cells, and crevicular 
fluid (Tenovuo, 1989). Saliva is a multifunctional secretion containing components that 
contribute to oral buffering, lubrication, enamel mineralization, taste, digestion and 
aggregation (e.g. agglutinins and mucin, MUC5B and MUC7) (Nieuw Amerongen and 
Veerman, 2002). In addition to its flushing and clearing effect saliva with its intricate 
composition provides reliable defense against external irritants and contributes to the 
maintenance  of  the  integrity  of  oral  homeostasis.  Constituents  that  are  either  directly  
antimicrobial or interfere with microbial colonization or nutrition include, for example, 
HDPs, secretory IgA, lactoferrin, lysozyme, sialoperoxidase, myeloperoxidase, chitinase, 
calprotectin, and chromagranin A (Schupbach et al., 2001; Vitorino et al., 2005; Shimada 
2006). 
Oral microbiota 
Along with its fine structural organization the oral cavity is unique with its specific 
microbiota comprising an astonishing variety of species residing in oral biofilms as well as 
in a planktonic state in the oral fluids. The predominant genera detected in the oral cavity 
include Streptococcus, Actinomyces, Veillonella, Fusobacterium, Porphyromonas, 
Prevotella, Treponema, Neisseria, Haemophilus, Eubacterium, Lactobacillus, 
Bifidobacterium, Capnocytophaga, Capnocytophaga, Peptostreptococcus, Staphilococcus, 
and Propionibacterium (Wilson, 2005). Resident commensal populations protect tissues 
from colonization by exogenous pathogens, promote normal development of host cell 
structure and function, ensure normal development of the immune system, and coordinate 
immune responses (Devine and Cosseau, 2008). More than 1000 bacterial species have 
been identified from the human mouth (Keijser et al., 2008; Paster et al., 2006), and only 
50-60% of these microorganisms can currently be cultured. A plausible explanation for 
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this intricacy is that some species have evolved to live within a biofilm community of 
interdependent species and cannot grow in monoculture (Wade, 2002; Handelsman, 2004). 
An investigation of the bacterial flora found in healthy volunteers showed that a given 
individual is colonized by 30 to 80 of the possible 1000 species at any given time (Aas et 
al., 2005). Within biofilms, resident bacteria gain significant advantages, that is, protection 
of host defenses and antimicrobial agents; expression of resistant phenotypes; and the 
development of food-webs and interactions such as quorum-sensing (Marsh, 2005; 
Roberts and Mullany, 2006; Bamford et al., 2009; Hojo et al., 2009; Keller and Costerton, 
2009). The beneficial role of commensal microbiota has been evaluated in various in vitro 
settings indicating that some microbes can suppress epithelial cell cytokine responses 
(Hasegawa et al., 2007; Cosseau et al., 2008); determine normal expression of immune 
mediators (Dixon et al., 2004);  and provide protection against colonization by exogenous 
microorganisms (Marsh, 2005). In general, microbial populations of the mouth are 
numerous, diverse and site-specific. 
The oral microbiota plays critical roles in human health and is directly linked to 
diseases such as dental caries and periodontal diseases. 
2.2 Common oral diseases 
Dental caries and periodontal disease are the most common bacterial diseases of man 
which result from an interaction between a susceptible host, commensal microbiota and 
the environment. Although some specific microorganisms have been implicated in the 
pathogenesis of these conditions, it is now recognized that they are not classical infectious 
diseases but rather a complex of diseases resulting from a breakdown in the homeostasis 
between the human host and microbiota. 
2.2.1 Dental caries 
2.2.1.1 Etiology and pathogenesis 
Dental  caries  remains  one  of  the  principal  diseases  in  the  oral  cavity  with  a  significant  
social impact. Caries is a result of the complex interaction between carbohydrates in food 
and cariogenic microorganisms in oral biofilms, influenced by the quality and quantity of 
saliva, and clinically manifested by demineralization and destruction of dental hard 
tissues.  Recent  development  in  molecular  analyses  have  shown  that  all  the  bacteria  that  
have been associated with caries belong to the normal microbiota of the oral cavity and  
dental caries is regarded as an endogenous infection (Fejerskov and Nyvad, 2003; 
Takahashi and Nyvad, 2008). Three major hypotheses for the etiology of caries have been 
supported: the specific plaque hypothesis, the non-specific plaque hypothesis, and the 
ecological plaque hypothesis (Loesche 1992; Marsh 1994; Martin et al., 2002). In light of 
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the ecological plaque hypothesis caries is a result of a shift in the balance of resident 
microbiota driven by changes in local environmental conditions (Aas et al., 2008). It is 
generally believed that all three parameters (microorganisms, the host, and environment) 
must  “act”  simultaneously  for  carious  lesions  to  develop  and  progress  and  to  become  
visually detectable (Shaw et al., 2008). 
A wide group of microorganisms are identified from carious lesions of which 
Streptococcus mutans, Lactobacillus acidophilus, and Actinomyces viscosus may be 
considered the main pathogenic species involved in the initiation and development of 
dental caries (Shivakumar et al., 2009). Streptococcus mutans, initially isolated in 1924, 
has been primarily implicated in this disease (Hamada and Slade, 1980; Loesche, 1986) 
and extensively studied throughout several decades. Some significant virulent traits of S. 
mutans that contribute to caries initiation and progression are: (i) initiation of biofilm 
formation by adherence and accumulation on the tooth surface that is promoted by its 
synthesis of insoluble, extracellular polysaccharides; (ii) production of numerous 
bacteriocins that kill other species, favouring its competition in dental biofilms; (iii) high 
efficiency in catabolizing carbohydrates and producing acids; and (iv) the ability to 
tolerate low pH (Belli and Marquis, 1991; Li and Burne, 2001; Kuramitsu, 2003; Scheie 
and Petersen, 2004). Various studies have shown that the expression of virulence traits by 
S. mutans requires multiple signal transduction pathways and complex regulatory 
networks. A signal peptide-mediated quorum-sensing system encoded by comCDE genes 
has been found to play a central role in regulation of genetic competence, bacteriocin 
production, biofilm formation and stress response (Li et al., 2001a, b, 2002a; van der 
Ploeg, 2005). Additionally, the genes that appear to be important for the cariogenicity of S. 
mutans, are regulated at transcription level (Jayaraman et al., 1997; Hiratsuka et al., 1998). 
Although numerous in vitro studies provide evidence of molecular mechanisms of S. 
mutans cariogenicity and this species appears the most extensively studied, in vivo test 
models do not generally validate basic laboratory findings. For example, Aas et al., (2008) 
have demonstrated that 10% of subjects with rampant caries do not have measurable levels 
of S. mutans. No detectable levels of S. mutans were also reported in 10 to 15 % of caries-
active subjects, thus indicating that the presence of S. mutans does not necessarily reflect 
caries activity (Beighton 2005). Furthermore, phenotype of a bacterium expressed in 
laboratory culture may not represent the properties expressed by the same organism in 
vivo. 
Key findings in the diversity of oral microbial species during past 10 years have 
changed the view of the etiology of caries. Molecular biology techniques have shown that 
more than 50% of the oral species are uncultivable by conventional methods (ten Cate 
2009). It is now recognized that caries results not solely because of the presence of S. 
mutans or any single organism in dental plaque, but it is rather the interaction of multiple 
acid-producing organisms such as low-pH non-mutans streptococci, Veilonella, 
Lactobacillus, Propionibacterium, Bifidobacterium that may be involved in the initiation 
of the disease (Aas et al., 2008; He et al., 2009; Matzourani et al., 2009). The ecological 
plaque hypothesis suggests that the cariogenic oral environment will select for increased 
proportions and numbers of acidogenic and aciduric microbiota with certain taxa 
exhibiting a reduced presence under these conditions (Matzourani et al., 2009). 
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2.2.1.2 Treatment and prevention 
The classical treatment plan for caries yet remains to be the operative approach of 
complete caries removal. A series of novel methods of caries removal have been 
described; including chemomechanical caries preparation, air abrasion, sono-abrasion, 
polymer rotary burs and lasers (Ricketts and Pitts, 2009). However, more scientific efforts 
are directed towards discovering effective methods for caries prophylaxis based on 
inhibiting the known mechanisms of caries development. The elimination of cariogenic 
bacteria from the oral cavity using antibacterial agents is one of the primary strategies for 
the prevention (Wicht et al., 2003; Caufiled, 2005; Altman et al., 2006; Modesto and 
Drake, 2006; Johansson et al., 2008). Fluoride treatment used worldwide has successfully 
limited caries progression, but was not sufficient to control this infectious disease even 
when used together with professional tooth cleaning and dietary counselling in 
populations exposed to cariogenic microbiota (Haugejorden and Birkeland, 2005; Yee et 
al., 2006; Akers, 2008; Carvalho et al., 2009). Polyphenols from plant stimulant beverages 
like cocoa, coffee, and tea have shown pronounced antimicrobial effect against S. mutans, 
and can additionally be implemented in the prevention of pathogenesis of dental caries 
(Ferrazzano et al., 2009). Polyphenols in stimulant beverages significantly reduce biofilm 
formation and acid production by S. mutans and S. sanguinis. Further, as an example, in 
vitro studies have shown that S. mutans is susceptible to methanol and aqueous extracts of 
Garcinia kola, Hibiscus sabdariffa (Afolabi et al., 2008). 
Sugar substitutes have a long history of being effective in caries reduction. The main 
sugar substitutes used are sorbitol and xylitol. Xylitol is not fermented by oral bacteria and 
is considered to be non-cariogenic while sorbitol in solution can be fermented slowly by 
mutant streptococci. Chewing sorbitol-sweetened gum does not cause a fall in plaque pH, 
however (Edgar, 1998). A regular consumption of xylitol lozenges can modify dental 
plaque resulting in marked reduction in the plaque acidogenicity (Splieth et al., 2009). 
Active and passive immunization strategies which target key elements in the molecular 
pathogenesis of mutans streptococci hold promise. Considerable caries reduction could be 
attained if colonization of S. mutans could be prevented or reduced at the time of eruption 
of both deciduous and permanent teeth. Thus, a successful vaccination directed against S. 
mutans could be a valuable adjunct to other caries-preventive measures. However, S. 
mutans being the sole target species in caries prophylaxis does not comply with the key 
principles of ecological plaque hypothesis. 
Bacteriotherapy further emerges as a fascinating approach in oral infectious disease 
management. A daily application of JH145, a naturally occurring LDH-deficient variant of 
S. rattus, could compete with S. mutans for its habitat on the tooth surface and thus 
contribute to caries prevention (Hillman et al., 2009). 
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2.2.2 Periodontal disease 
2.2.2.1 Etiology and pathogenesis 
Periodontal disease has been described as “a heterogeneous group of pathoses 
characterized by a predominance of specific infectious agents in the face of inadequate 
local host defenses” (Slots, 2005). The definition reflects the complexity of periodontal 
disease. 
A primary risk factor considered in the etiology and progression of periodontal disease 
is the infection by specific bacterial pathogens. The actions of bacterial virulence factors, 
directly or indirectly through the activation of the immune system, cause swelling, 
inflammation, and gingival pocket formation. The balance between protective and 
destructive immune responses is a key determinant of disease progression. This balance is 
strongly influenced by the host response to the challenge caused by subgingival bacteria 
(Sakamoto et al., 2005; Teng, 2006a, Teng, 2006b). Socransky et al., (1998) have 
formulated a color coded complex for periodontal pathogens with respect to their 
destructive potential. The “Red complex”, which includes Porphyromonas gingivalis, 
Treponema denticola, and Tannerella forsythia, strongly correlated to chronic periodontal 
disease, and the first two species together with Aggregatibacter actinomycetemcomitans 
are currently recognized as the main causative species of periodontal disease (Borrell and 
Papapanou, 2005; Nørskov- Lauritsen and Kilian, 2006). 
Destruction of the periodontal ligament and resorption of the alveolar bone leading to 
tooth  loss  is  the  hallmark  of  periodontal  disease.  Since  host  and  microbiota  interactions  
are dynamic, disease may arise at the mucosal surface of a susceptible host when a 
perturbation occurs in the epithelial environment, for example, when the host becomes 
immunocompromised,  or  as  a  result  of  the  unintended  (in  an  evolutionary  sense)  
consequences of bacterial activity (Galan and Zhou, 2000). The initial interface between 
the host and the potentially periodontopathic organisms, such as P. gingivalis and A. 
actinomycetemcomitans, is the epithelial layer that lines the subgingival crevice. Epithelial 
cells are both a physical barrier to infection and a component of a network that efficiently 
signals microbial intrusion to the immune cells to insure effective mobilization of the 
innate and specific defense mechanisms (Kagnoff and Eckmann, 1997). Studies have 
shown that several periodontal pathogens, A. actinomycetemcomitans, P. gingivalis, F. 
nucleatum, and T. denticola, can effectively invade and exist in oral epithelial cells 
(Sreenivasan et al., 1993; Rudney et al., 2005; Vitkov et al., 2005; Sakakibara et al., 
2007). Furthermore, intracellular P. gingivalis is able to inhibit apoptosis, a feature that 
may contribute to bacterial persistence and chronic, slowly progressing tissue destruction 
(Nakhjiri et al., 2001). Localization of bacteria in host tissues provides an ideal position 
from which the microorganism can effectively deliver toxic molecules and enzymes and at 
the same time can avoid host defense mechanisms. For example, P. gingivalis is  able to 
inhibit production of IL-8 by epithelial cells, which may provide the microorganism with 
an advantage in evading polymorphonuclear(PMN)-mediated killing (Dareveau et al., 
1998). 
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Host tissue damage can be due to bacterial properties resulting directly in degradation 
of host tissues and those causing release of biologic mediators from host tissue cells that 
lead to tissue destruction. A large group of enzymes produced by periodontal 
microorganisms appear capable of degrading host tissues and intercellular matrix 
molecules. Bacterial products may perturb the immune system resulting in tissue 
destruction. The proportion of P. gingivalis, A. actinomycetemcomitans, T. forsythia and 
the number of CD4(+) T are higher in active than in inactive sites (Silva et al., 2008). 
Pathologically increased activity of matrix metalloproteinases (MMP-2; MMP-8; 
MMP-9; MMP-13) in inflamed periodontal structures leads to periodontal destruction due 
to collagen degradation (Biyiko?lu et al., 2009; Gu et al., 2009; Marcaccini et al., 2009; 
Yamazaki-Kubota et al., 2009). Furthermore, some periodontal pathogens may indirectly 
contribute to tissue damage by induction of host tissue proteinases such as elastase and 
MMPs (Pattamapun et al., 2003; Tiranathanagul et al., 2004; Bodet et al., 2007; Guam et 
al., 2008). A. actinomycetemcomitans and P.gingivalis can elevate MMP-2 secretion in 
human periodontal ligament fibroblasts (PDLFs), indicating that periodontal pathogens 
play an important role in tissue destruction and disintegration of extracellular matrix in 
periodontal diseases (Chang et al., 2002). 
2.2.2.2 Treatment and prevention 
Traditionally periodontal disease treatment is a four-phase approach including non-
surgical periodontal therapy, surgical procedures, restorative treatment, and supportive 
care or maintenance. The foremost goal in periodontal therapy is the elimination or 
reduction of the pathogenic potential of dental plaque.  However, even with appropriate 
treatment and improved oral hygiene many patients fail to respond to therapy unless 
certain factors (e.g. smoking, uncontrolled diabetes) are also eliminated. 
One strategy to prevent periodontal disease may be the controlling of factors that 
disrupt the microbial ecological balance from a symbiotic and healthy to a host-pathogen 
relationship which then leads to disease (Kinane et al., 1999). Systemic and local 
antibiotic applications have been used as adjunct to conventional periodontal therapy. 
However, because of the chronic nature of periodontitis antibiotic medications are not 
generally used except in patients who do not respond to conventional therapy. 
Inappropriate use of antibiotic agents can lead to overgrowth of potentially pathogenic 
organisms and development of bacterial drug resistance. 
A novel prophylactic strategy in periodontal disease management that merits further 
investigations is the replacement of common periodontal pathogens by commensal oral 
microbes. Teughels and coworkers have tested the hypothesis that the subgingival 
application of S. sanguinis KTH-4, S. salivarius TOVE and S. mitis BMS after mechanical 
debridement would enhance the microbial shift away from periodontopathogens (Teughels 
et al., 2007). A significant delay in recolonization of periodontal pockets by A. 
actinomycetemcomitans, P. gingivalis, P. intermedia, and Tannerella forsythia after root 
planing was observed when the above species were locally applied. 
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Scientific understanding of molecular mechanisms in the development and progression 
of common oral diseases can foster the implementation of natural host defense 
mechanisms to combat oral infections. The application of “health-promoting” bacteria for 
therapeutic purposes is one interesting field in this regard. 
2.3 Probiotics from the oral health perspective 
2.3.1 Probiotics 
2.3.1.1 Emergence and definition of the term 
The word probiotic is derived from the Greek “probiosis” meaning “for life” and generally 
applies to bacteria causing no harm to the host. The probiotic concept dates back over 100 
years, and associates with the name of the Ukranian bacteriologist and Nobel Laureate Ilie 
Metchnikoff, who proposed the scientific rationale for the beneficial effects of lactic acid 
bacteria. In 1888 while working in the Pasteur Institute in Paris, Ilie Metchnikoff 
emphasized a theory that putrefactive-type fermentation products by some gut pathogens 
may be the cause for autointoxication of the macroorganism. Furthermore, the intake of 
bacteria involved in yogurt fermentation, L. bulgaricus and Streptococcus thermophilus, 
can effectively suppress metabolic activity of pathogenic intestinal species thus 
maintaining health. He claimed that the longevity of some populations in Bulgaria, Turkey 
and Armenia was due to regular consumption of fermented milk products rich in live lactic 
acid bacteria (LAB). The scientist has promoted the idea that LAB in yogurt may 
neutralize deleterious effects of gut pathogens, thus extending life span. He further 
contributed to the adoption of the name of the species, L. bulgaricus, one of the essential 
yogurt starter microorganisms. This also meant the birth of modern dairy industry 
(Meurman, 2005). 
Despite inconclusive evidence of health effect of yogurt bacteria research interest 
intensified in the later years. Ferdinand Vergin was the first (1954) to introduce the term 
“probiotic” mainly opposing it to antibiotics. Kollath (1954) used the term to designate 
“active substances that are essential for healthy development of life”. Lilly and Stillwell 
(1965) contributed to the adoption of probiotics as scientific term providing evidence that 
bacteria secrete substances that stimulate the growth of another. The definition underwent 
further modifications broadening its meaning. Parker (1974) defined them as: “organisms 
and substances which contribute to intestinal balance”. The closest to contemporary 
meaning of probiotics has been given by Roy Fuller (1989): “a live microbial feed 
supplement which beneficially affects the host animal by improving the intestinal 
microbial balance”. Yet probiotic activity was limited to live bacterial species. However, 
accumulation of new research data contributed to the understanding of probiotic activities 
beyond the scope of gastrointestinal tract and bacterial cell fractions were also claimed 
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effective. Although the concept of probiotics remains open to further modifications, in 
2002 the Joint Food and Agriculture Organization/World Health Organization Working 
Group (FAO/WHO) officially formulated the term “probiotics”: “Live microorganisms 
which when administered in adequate amounts confer a health benefit on the host”. This 
definition was adopted by the International Scientific Association for Probiotics and 
Prebiotics (Reid et al., 2003).  The definition retains the historical elements of the use of 
living organisms for health purposes but does not restrict the application of the term only 
to oral probiotics with intestinal outcomes.  
Probiotics can also target the oral cavity, nasopharynx, stomach, vagina, bladder and 
skin. Another implication of the FAO/WHO definition is that unless strains are shown to 
confer clinically established physiological benefits, they should not be referred to as 
probiotics (Reid et al., 2003). Under the formulation of the latter definition probiotics are 
linked to food and to food only, thus excluding any reference to the term “biotherapeutic 
agents”. However, emerging data suggest that while viable organisms may be most 
effective for specific effects, non-viable probiotic organisms (abiotics) may be efficacious 
in specific situations (Salminen et al., 1999; Shortt, 1999). It is likely that the abiotic idea, 
if accepted, will further broaden the health potential of the probiotic concept in the future 
(Shortt, 1999).  
The principal microorganisms in use as probiotics belong to the genera Lactobacillus 
and Bifidobacterium. However, other genera including Escherichia, Enterococcus, and 
Saccharomyces are  also  used.  Lactobacilli  and  bifidobacteria  constitute  the  two  most  
important probiotic groups under consideration owing to their recognition as members of 
the indigenous microbiota of humans, their history of safety and the general body of 
evidence that supports their positive roles. At this stage, phylogenetics has recognized 97 
species of lactobacilli (Dellaglio and Felis, 2005), 18 of which are considered to be of 
some interest in probiotics; and 31 species of Bifidobacterium, 11 of which have been 
detected in human feces (Sanders, 1999). Lactic acid bacteria are associated with habitats 
that are rich in nutrients, such as various food products. They can be found in soil, water, 
sewage,  and  they  can  ferment  or  spoil  food.  Certain  LAB species  are  inhabitants  of  the  
human oral cavity, the intestinal tract, and the vagina, and may have a beneficial influence 
on these human ecosystems (Holzapfel et al., 2001). 
2.3.1.2 Beneficial effects of probiotics 
Numerous health benefits have been proposed to result from consumption of probiotic 
bacteria. Although the specific mechanisms involved in the many suggested benefits have 
not been completely established, evidence suggests that probiotics can influence various 
disease conditions in a positive manner. Table 1 outlines the most common clinical 
conditions with a positive outcome after probiotic administration. 
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Table 1. Clinical conditions improved by probiotic intake 
Disorder Probiotic Patient 
group 
Duration Clinical effect Reference 
GI disorder 
Ulcerative 
colitis 
E. coli Nissle 1917 116 12 
months 
Induction of 
remission; 
prevention of 
relapses 
Rembacken et 
al., 1997 
 E. coli Nissle 1917 120 12 weeks Maintaining the 
remission 
Kruis et al., 
2004 
 B. longum 120 4 weeks Improved 
systemic 
function 
Fujimori et al., 
2009 
 VSL#3 29 12 
months 
Remission 
maintenance 
Miele et al., 
2009 
 L. rhamnosus GG 187 12 
months 
Prolongation of 
relapse-free 
time 
Zocco et al., 
2006 
 E. coli Nissle 1917 327 12 
months 
Induction of 
remission 
Kruis et al., 
2001 
 Saccharomyces 
boulardii 
25 4 weeks Induction of 
remission 
Guslandi et al., 
2003 
Crohn`s 
disease 
 
Saccharomyces 
boulardii 
34 3 months Improved 
intestinal 
permeability 
Garcia Vilela et 
al., 2008 
 L. johnsonii 98 6 months Postsurgical 
Crohn`s disease 
recurrence 
Marteau et al., 
2006 
 E. coli Nissle 1917 24 3 months Relapse rate 
decreased 
Guslandi et al., 
2000 
 Genetically 10 7 days Decrease in Braat et al., 
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modified L. lactis 
(LL Thy12) 
delivering IL-10 
disease activity 2006 
Pouchitis VSL#3 36 12 
months 
Maintaining the 
remission 
Mimura et al., 
2004 
 VSL#3 23 4 weeks Prolongation of 
remission 
Gionchetti et 
al., 2007 
Lactose 
maldigestion 
L. acidophilus 20 On 
intake 
Decreased 
symptoms of 
lactose-
maldigestion 
Montes et al., 
1995 
Diarrhea 
episodes 
L. rhamnsosus GG 204 15 
months 
Reduction of 
diarrhea 
episodes in 
children 
Oberhelman et 
al., 1999 
 L. rhamnosus 
19070-2; L. 
reuteri DSM 
12246 
69 5 days Reduction of 
diarrhea phase 
Rosenfeldt et 
al., 2002 
 L. paracasei ST 11 230 5 days Improved 
management of 
non-rotavirus 
diarrhea 
Sarker et al., 
2005 
 L.rhamnosus GG 140 5 days Shorten 
diarrhea 
duration 
Guandalini et 
al., 2000 
 Probiotic 
combination 
75 5 days Shorten 
diarrhea periods 
Teran et al., 
2009 
Allergy states L. acidophilus 
NCFM; B. lactis 
47 4 months Prevention of 
pollen-induced 
infiltration of 
eosinophils 
Ouwehand et 
al., 2009 
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 Lactobacillus F19 89 7 months Prevents early 
manifestation of 
allergy 
West et al., 
2009 
 L.GG; L.gasseri 
TMC0365 
40 10 weeks Decreased 
allergic rhinitis 
symptoms 
Kawase et al., 
2009 
 
Mechanisms of action explaining the beneficial probiotic effects, though still unclear, may 
include the modulation of host immune response leading to strengthening of the resistance 
to  pathogenic  challenge;  alteration  of  the  composition  and  metabolic  activity  of  host  
microbiota at the specific location; interference with pathogen adhesion and growth 
inhibition (Hatakka  and Saxelin, 2008). 
2.3.1.3 Selection criteria for probiotic candidates 
A  wide  range  of  requirements  have  been  discussed  as  related  to  various  applications  of  
probiotics (Lee, 2009), but among key selection criteria with emphasis on human health 
are: 
? Adhesion and colonization (at least transitory) of human body. Adhesion may 
increase the retention time of a probiotic and place bacteria and host surfaces 
(body fluids and epithelial cells) in close contact thus facilitating further 
probiotic activity; 
? Enhancement of the non-specific and specific immune response of the host; 
? Production of antimicrobial substances and competition with pathogens for 
binding sites; 
? Survival and resistance to human defense mechanisms during the oro-gastro-
intestinal transit; 
? Human safety. 
Additionally, the probiotic candidate should (1) be of human origin; (2) be non 
pathogenic; (3) confer clinically established physiological benefits; and (4) maintain 
viability and activity throughout product manufacture and processing (Dunne et al., 1999; 
Reid et al., 2003). Generally the list of criteria for probiotic selection is application-based 
and depends on the specific probiotic effects desired and the target site of action. 
Oral cavity with its complex anatomy with both soft and hard tissues and functional 
integrity is a new area for studies of probiotic therapy in the treatment and prevention of 
most common disorders in the mouth. Species investigated from an oral health perspective 
are given in Table 2. 
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Table 2. Probiotic candidates for the oral cavity 
Lactobacillus Bifidobacterium Streptococcus Propionibacterium Weissella 
 
L. reuteri  B. lactis S. salivarius 
K12 
P. freudenreichii W. cibaria 
L. plantarum B. longum S. thermophilus   
L. rhamnosus B. infantis    
L. salivarius     
L. acidophilus     
L. casei     
L. johnsonii     
 
Among the selection criteria with relevance of probiotics to the mouth are: 
? Attachment, adhesion, and oral colonization; 
? Resistance to oral defence mechanisms; 
? Production of antimicrobial substances and competition with pathogens for 
binding sites; 
? Carbohydrate and protein utilization patterns; 
? Enhancement of the non-specific and specific immune response of the host; 
? Safety to oral ecology and oral structures. 
2.3.1.3.1 Attachment, adhesion, and oral colonization 
The evidence is scarce regarding the question whether probiotics permanently reside in the 
human body and in the mouth, in particular (Petti et al., 2001; Yli-Knuuttila et al., 2006). 
However, it can be anticipated that among the 103 – 104 CFU/g lactobacilli found in the 
oral cavity (Bernardeau et al., 2008) there are species/strains capable of exerting probiotic 
properties. Bacteria reside in the mouth either in planktonic state or are finely integrated in 
biofilm on various oral surfaces. Oral biofilms are dynamically changing and develop 
increasingly complex structures as they mature. Interaction between species is 
characteristic in biofilms. Some species may depend on others to provide favorite 
environment for colonization. Furthermore, bacteria in biofilms differ physiologically 
from their planktonic counterparts and tend to be much more resistant to environmental 
factors and antimicrobial agents. It has been established that distinct genes become active 
when planktonic bacteria bind to surfaces and grow in biofilms (Burne et al., 1999; 
Rudney, 2000). On the other hand, saliva is the essential medium in the mouth 
contributing to the microbial diversity. It plays an integral role in propagating oral 
biofilms. Salivary flow can easily lead to detachment of some microbes from biofilm 
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surfaces and thus modulate microbial colonization. Furthermore, as complex medium 
saliva contains different proteins with bactericidal, bacteriostatic, or inhibitory activity that 
collectively may affect a variety of species in planktonic state (Germaine and Tellefson, 
1986; Rudney et al., 1991; Hahnel et al., 2008; Grölsch et al., 2009). Biofilm species 
composition can also depend on phenomena like auto- or co-aggregation that may prevent 
microorganisms from establishing themselves in the biofilms. Hence by taking into 
consideration the multifaceted nature of biofilm development and multivariate species 
interactions we can acquire better understanding and interpretation of studies with 
probiotics in the oral cavity. 
There are very few studies of the colonization of probiotic bacteria in the oral cavity, 
and the results are contradictory. The pattern of oral colonization by probiotic species has 
been found to be transient and gradually diminished soon after probiotic administration 
period ended (Bussscher et al., 1999; Petti et al., 2001; Yli-Knuuttila et al., 2006). 
Therefore, it is necessary to consider that the associations and mechanisms less intricate 
and more transient than those of native microflora may mediate probiotic effects. On the 
other hand probiotic administration early in life may provide those species the opportunity 
to interact with host receptors early and subsequently integrate in microbial communities 
resulting in permanent condition. In a study comparing species variability in the mouth 
and feces Ahrne et al. (1998) have discovered that species most frequently recovered from 
the rectal as well as from the oral mucosa were L. plantarum and L. rhamnosus, which 
were present in 52% and 26% of the individuals, respectively. However, this study did not 
define those strains as permanent colonizers of the two sites tested or whether the mouth is 
their natural habitat. The most common species of lactobacilli recovered from saliva of a 
Thai population were L. fermentum and L. rhamnsous (Teanpaisan  et  al.,  2006).  A  
promising finding was that lactobacilli population differed between healthy individuals 
and  those  with  periodontal  disease.  Koll-Klais  et  al.  (2005)  have  observed  that  healthy  
persons are populated by L. gasseri and L. fermentum, whereas the predominant species in 
periodontitis patients was L. plantarum while the first two were undetectable. 
Observations by this study group showed that microorganisms with probiotic properties 
may  indeed  exist  and  reside  in  the  oral  cavity.  However,  the  complexity  of  biofilm  
development and interspecies interactions require more thorough investigations in order to 
assert true probiotic candidates with activity in the oral cavity. 
The mechanism of adhesion to oral surfaces is an issue of importance for the long term 
probiotic effect. The capacity of probiotics to adhere to surfaces of the oral cavity can 
avoid or at least reduce rapid clearance from the environment. Among the different assays 
available to study the adhesion phenomenon, two model systems predominate: systems 
using saliva-coated hydroxylapatite (HA) and hydroxylapatite coated with buffers, 
proteins, and other substances (Ostengo and Nader-Macias, 2004). Probiotics and putative 
probiotic strains have been shown to vary extensively in their adhesiveness to saliva-
coated surfaces. Lactobacilli have shown better adherence than bifidobacteria to saliva-
coated hydroxyapatite beads and polystyrene plates (Haukioja et al., 2006). Furthermore, 
interplay between saliva and probiotics may additionally modify composition of salivary 
pellicle thus altering the attachment pattern. In vitro removal of a heavy molecular weight 
protein band that contained salivary agglutinin gp340 has been observed after incubation 
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of saliva with four commercially available probiotic strains (Haukioja et al., 2008). The 
mechanisms of adhesion of lactobacilli involve hydrophobicity and surface charge, as well 
as specific carbohydrate and/or proteinaceous components (Lorca et al., 2002). The 
interaction between bacterial and HA surfaces have been shown to depend not only on the 
nature and number of available anchoring groups, but also on the calcium ions in the 
medium that bind the functional groups of the bacteria to the biomaterial (Venegas et al., 
2006). 
The adhesion of probiotic bacteria to oral soft tissues is another aspect that promotes 
their  health  effect  to  the  host.  Cell  adhesion  is  a  complex  process  involving  contact  
between the bacterial cell and interacting surfaces. Secretome studies can provide valuable 
information about bacterial structures responsible for binding to host surfaces. The domain 
composition of the L. plantarum proteins predicted appeared to be involved in the 
adherence to extracellular macromolecules (Boekhorst et al., 2006). 
2.3.1.3.2 Resistance to oral defence mechanisms 
It  is  generally  considered  that  to  be  able  to  exert  its  beneficial  effect  the  probiotic  
candidate should survive the oro-gastrointestinal passage. Ingested probiotics are exposed 
first to saliva which mediates the contact with hard and soft oral tissues. During this first 
step of contact with tissues resistance to environmental factors in the mouth are of 
paramount importance for bacteria to survive. Salivary proteins such as lysozyme, 
lactoferrin, histatin, salivary peroxidase, cystatins, and secretory IgA can collectively 
affect viability or cell surface morphology of probiotic species and further affect their 
adhesion and metabolic activity. Saliva can kill or damage species in planktonic state as 
well as mediate intra- and interspecies aggregation, thus additionally affecting adhesion. 
The role of saliva on microbial establishment can be contradictory, however, inhibiting 
colonization on one hand (by growth inhibition, killing, or prevention of adherence to host 
tissues), and promoting microbial colonization, on the other hand (Bosch et al., 2003). In 
vitro studies testing probiotic survival in saliva have shown that Lactobacillus and 
Bifidobacterium strains cannot grow in saliva but remain viable after 24 hours of 
incubation (Haukioja et al., 2006). Lysozyme pretreatment has been observed to 
significantly reduce the adhesion of L. rhamnosus GG, L. rhamnosus Lc705 and L. casei 
Shirota. However, the adhesive properties of L. johnsonii La1 and B. lactis Bb12 remained 
unaffected. These results emphasize the strain-specific response to proteolytic enzymes 
and this feature needs to be considered when selecting probiotics for the oral cavity. 
2.3.2 Clinical relevance of probiotics in the oral cavity 
Probiotic relevance in the management of common oral diseases has been advocated in a 
number  of  clinical  studies.  Table 3 lists the species/strains that have been observed to 
positively affect infectious oral diseases. 
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Table 3. Clincal trials with positive effect after probiotic administration 
Oral disease Probiotic Vehicle of 
administration 
Duration 
of the 
study 
Result Reference 
Dental 
caries 
L. rhamnosus 
GG 
Cheese 3 weeks Reduction of 
S. mutans 
Ahola et 
al., 2002 
 L. rhamnosus 
GG 
Milk 7 months Lower S. 
mutans 
counts 
Näse et 
al., 2001 
 Bifidobacterium 
DN-173010 
Yogurt 4 weeks Reduction of 
S. mutans 
Çaglar et 
al., 2005 
 B. animalis 
subsp. lactis 
DN-173010 
Fruit yogurt 4 weeks Reduction of 
S. mutans  
Cildir et 
al., 2009 
Gingivitis 
and 
periodontitis 
L. reuteri Chewing 
tablet 
2 weeks Improved 
gingival 
health and 
reduced 
plaque 
accumulation 
Krasse et 
al., 2006 
 L. reuteri Chewing gum 2 weeks Improved 
bleeding on 
probing, and 
decrease of 
GCF volume 
Twetman 
et al., 
2009 
 L. casei 37 Periodontal 
dressing 
Several 
days in 
periodontal 
dressing 
Reduction of 
periodontal 
pathogens 
Volozhin 
et al., 
2004 
C. albicans 
infections 
L. rhamnosus 
GG; P. 
Cheese 16 weeks Decreased 
prevalence 
Hatakka 
et al., 
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freudenreichii 
ssp.shermanii 
JS 
of 
C.albicans 
2006 
 
2.3.2.1 Probiotics and dental caries 
The first randomized, double-blind, placebo-controlled intervention study of L. rhamnosus 
GG effect on dental caries was completed in 2001; the study included 594 children, 1-6 
years old, who consumed milk for 7 months (Näse et al., 2001). Probiotic milk was able to 
reduce S. mutans counts at the end of the trial and a significant reduction of caries risk was 
also observed. S. mutans reduction was also achieved after consumption of L. rhamnosus 
LC 705, Bifidobacterium DN-173 010, and B. lactis Bb-12 in cheese, yogurt, or ice-cream 
as vehicles (Ahola et al., 2002; Çaglar et al., 2005; Çaglar et al., 2008). Fermented dairy 
products being a favorable habitat for lactobacilli are generally used as vehicles for 
probiotic administration. However, for the scope of the oral cavity several other means of 
administration have been assessed. A tablet, a telescopic straw, a lozenge, and a chewing 
gum containing probiotics have shown reduction of common caries pathogen after 3-week 
regular intake (Çaglar et al., 2006; Çaglar et al., 2007; Çaglar et al., 2008). The observed 
positive correlation between probiotic intake and reduction in caries pathogen counts 
might be a useful strategy in caries prophylaxis for some special risk groups. For example, 
orthodontic patients wearing fixed appliances can experience higher caries risk during 
treatment.  Cildir  et  al.  (2009)  have  shown  that  a  probiotic  intake  of  B. animalis subsp. 
lactis DN-173010 can positively reduce salivary mutans streptococci in orthodontic 
patients. 
Possible explanation for the clinical results of probiotic intake may be the competition 
for binding sites in oral biofilms as shown in some in vitro studies (Haukioja et al., 2008). 
However, this area also calls for more in-depth studies. 
2.3.2.2 Probiotics and periodontal disease 
Only few clinical studies outlining probiotic effectiveness in periodontal disease have 
been published to date. From the periodontal health perspective it should be noted that the 
composition of lactobacilli species differs in healthy and periodontitis patients and that 
obligately homofermentatives are less prevalent in chronic periodontitis (Koll-Klais et al., 
2005). A fourteen-day intake of L. reuteri led to the establishment of the strain in the oral 
cavity and significant reduction of gingivitis and plaque in patients with moderate to 
severe gingivitis (Krasse et al., 2006). Salivary inflammatory markers of periodontal 
disease can be positively affected in smokers after L. salivarius WB21 tablet form 
administration for eight weeks (Shimauchi et al., 2008). Periodontal inflammation has 
been reduced after the intake of probiotic tablets (Bifidumbacterin and Acilact) available 
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on the Russian market (Grudianov et al., 2002). Studies from Russia have also shown that 
a periodontal dressing containing L. casei 37 can reduce the number of most common 
periodontal pathogens and extend remission up to 10 – 12 months (Volozhin et al., 2004). 
Possible explanation to the results might be the inhibitory effect of probiotics on pathogen 
growth  thus  altering  the  composition  of  oral  biofilm.  Due  to  its  ability  to  inhibit  P. 
gingivalis, L. salivarius TI 2711 was given for 4 or 8 weeks in a tablet to healthy 
volunteers at a concentration of 2x107 CFU/ml. A significant reduction of blackpigmented 
rods in saliva was observed (Ishikawa et al., 2003). Additional finding in this study was 
the increase of pH to neutral after treatment, thus highlighting both caries and periodonto-
prophylactic properties. The effectiveness of the latter Lactobacillus strain has been 
confirmed by Matsuoka et al., (2006). 
A proposed mechanism of action of probiotics is strengthening the mucosal barrier via 
tropic effects on the epithelium and stimulating both the innate and adaptive immune 
response. A double-blind, placebo-controlled clinical trial with L. reuteri ATCC 55730 
and ATCC 5289 taken in a chewing gum for 10 min twice daily has shown reduction of 
pro-inflammatory cytokines TNF-? and IL-8 in gingival crevicular fluid (Twetman et al., 
2009). 
Because of the broad diversity of species residing in the mouth new probiotic 
candidates may be anticipated to emerge adding to the array of already known strains. A 
novel concept favoring periodontal health has been introduced by Teughels and co-
workers (Teughels et al., 2007; Nackaerts et al., 2008) suggesting re-colonization of the 
gingival pocket after scaling and root planning by species like S. sanguinis KTH-4, S. 
salivarius TOVE and S. mitis BMS these strains then thought to be able to inhibit 
adhesion of common periodontal pathogens. The foundation of the re-colonization concept 
stands on the principle that subgingival application of oral streptococci would enhance the 
microbial shift away from periodontopathogens. 
2.3.2.3 Probiotics and other oral disorders 
Among other oral conditions that may be favorably affected by probiotic administration 
are Candida infections and halitosis. 
Halitosis, foetor ex ore, has mainly been ascribed to the production of volatile sulfur 
compounds (VSC) by Gram negative anaerobes residing in periodontal pockets and on the 
tongue dorsum. Halitosis has been significantly improved in subjects after probiotic 
intake. S. salivarius K12 taken in a lozenge after a mouth wash led to reduction of VSC 
levels in 85% of the subjects (Burton et al., 2006). Furthermore, L. salivarius has been the 
most prominent species detected in healthy subjects, whereas in individuals with halitosis 
it  was  almost  undetectable  or  only  at  very  low levels  (Kazor  et  al.,  2003).  W. cibaria is 
another species with probiotic properties which has been shown to reduce VSC production 
both in vitro and in vivo (Kang et al., 2006). A contributing factor to the malodor 
reduction can be the ability of W. cibaria to  co-aggregate  with  species  known  for  their  
VSC production (F. nucleatum, for example). The aggregation thus affects the source for 
malodorous compounds in the oral cavity (Kang et al., 2005). 
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Candida albicans is the commonest pathogen of oral fungal infections. Probiotic 
applications may alleviate symptoms and reduce pathogenic potential of Candida species. 
A 16-week probiotic intervention study demonstrated a significant reduction by 75% of 
high yeast counts in the elderly (Hatakka et al., 2007). The intake of L. rhamnosus GG 
containing cheese associated with control of oral Candida also led to reduction of the risk 
of hyposalivation as reported by the same authors. Although this is the only study 
published on the role of probiotics on yeast infection in humans two other in vivo studies 
on mice have shown that lactobacilli might indeed be effective in controlling oral 
candidiasis.  Elahi  et  al.,  (2005)  have  demonstrated  a  higher  clearance  of  C. albicans in 
mice fed with L. acidophilus compared to the control group. However, in another study no 
noticeable delay in colonization of the oral cavity by C. albicans of immunocompromized 
mice was achieved when heat killed L. casei and L. acidophilus cells were given (Wagner 
et al., 2000). 
2.4 L. delbrueckii subsp. bulgaricus as a probiotic 
The  discovery  of  Lactobacillus bulgaricus relates to Stamen Grigorov, a Bulgarian 
microbiologist who in 1905, in the laboratory of Professor Masole in Geneva, isolated the 
species from yogurt and thereafter the microorganism was named after the country. 
“Lactobacillus bulgaricus” was formally described by Orla-Jensen in 1919 and validated 
in 1971 with the study of Rogosa and Hansen (1971). After a number of different studies, 
Weiss et al. (1984) proposed the union of Lactobacillus delbrueckii, Lactobacillus 
leichmannii, Lactobacillus lactis and Lactobacillus bulgaricus under  the  name  of  L. 
delbrueckii, and thereafter the name of the former “Lactobacillus bulgaricus” was 
changed in Lactobacillus delbrueckii subsp. bulgaricus. Within the species, three 
subspecies were recognized to exhibit DNA-DNA homologies of 90-100% among each 
other (Howey et al., 1990; Torriani et al., 1997; Germond et al., 2003). Consequently, they 
cannot be easily identified, not even by molecular methods, and can be mistakenly 
confused if only the phenotypic characteristics are known (Milliere et al., 1996; 
Vandamme et al., 1996; Giraffa et al., 2003).   
L. delbrueckii subsp. bulgaricus is a Gram-positive, non-motile, obligatory 
homofermentative, catalase-negative rod (Figure  1).  Its  DNA  has  49-51  %  GC  ratio  
(Hammes and Vogel, 1995), which is significantly higher compared to the GC content of 
other lactobacilli in the genus (Nicolas et al., 2007). Carbohydrate fermentation results in 
99.5 % D- and 0.5 % L-lactic acid. L. bulgaricus encodes many partial carbohydrate 
metabolic pathways and shows a distinct preference for growth in lactose rich media. It 
maintains extensive proteolytic and amino acid transport systems which are useful in the 
protein-rich milk environment (Klaenhammer et al., 2008). L. delbrueckii subsp. 
bulgaricus belongs to thermophylic lactic acid bacteria and temperatures between 43-46°C 
are optimal for its growth. Lactic acid bacteria can survive in anaerobic conditions because 
oxygen is not needed for energy metabolism. They can tolerate aerobic environments as 
well. A pH modified MRS (pH 4.58) agar and anaerobic incubation at 43°C can be used to 
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selectively enumerate L. delbrueckii subsp. bulgaricus from a product (Tharmaraj and 
Shah, 2003). 
 
                                      
Figure 1. Scanning electron microscopy image of rod-shaped L. delbrueckii subsp. bulgaricus 
(courtesy of Kari Lounatmaa). 
Lactobacillus delbrueckii subsp. bulgaricus is  one  of  the  two  bacteria  required  for  the  
production of yoghurt. It plays an essential role in the development of the organoleptic 
(Ott et al., 1997; Petry et al., 2000), hygienic and perhaps probiotic properties of this food 
(Hassan and Frank, 2001). Table 4 gives some of fermented milk products where L. 
bulgaricus is used for production. 
Table 4. Dairy products containing L. delbrueckii subsp. bulgaricus (source Lee and Wong, 1993). 
Product Starter microorganism 
Yogurt L. delbrueckii ssp. bulgaricus, Str. 
thermophilus 
Bulgarian butter milk L. delbrueckii ssp. bulgaricus 
Dahi L. delbrueckii ssp. bulgaricus, Str. 
thermophilus, Leu. mesenteroides ssp. 
cremoris 
Kefir L. lactis ssp. lactis, L. lactis ssp. cremoris, 
L. lactis diacetilactis, L. delbrueckii ssp. 
bulgaricus, Str. thermophilus, L. 
helveticus, L. kefir, Saccharomyces ssp. 
Kumys L. acidophilus, L. delbrueckii ssp. 
bulgaricus, Saccharomyces lactis, Torula 
koumiss 
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Yogurt has been considered the primary habitat of the species (Davis, 1975) because the 
bacterium is highly adapted to milk environment (Norbert et al., 1983) and is also able to 
resist low pH values (Delley and Germont, 2002). However, the millennium long tradition 
of fermented milk production has propelled the search for plants serving as sources for L. 
bulgaricus isolation. In a historical perspective plant extracts have been added to sheep 
milk and then heated until a dense milk coagulum is obtained (Markoff, 1925). Several 
plants have been reported as habitats for L. bulgaricus: Cornus mas, Ononis spinosa, 
Berberis vulgaris, Paliurus aculeatus, Matricaria chamomilla, Prunus spinosa (Girginoff, 
1959; Kantardjiev, 1962; Stefanova, 1985; Mychailova et al., 2007). Glucose, fructose, 
mannose, and sucrose availability on leaf and stem surfaces of these plans are recognized 
as nutritients that provide optimal growth conditions for the microbial species (Tukey, 
1970; Schaffner and Beuchat, 1986; Andrews and Harris, 2000; Mercier and Lindow, 
2000; Lee, 2001; Michaylova et al., 2005). 
Relative  debate  exists  about  whether  or  not  yogurt  starter  bacteria  such  as  L. 
bulgaricus should be considered probiotics. In vitro models and few clinical trials have 
shown that yogurt bacteria cannot survive in the gastrointestinal tract thus being unable to 
permanently colonize the gut (Shah and Jelen, 1990; Marteau et al., 1997; del Campo et 
al., 2005; Garcia-Albiach et al., 2008). In contrast to the intestinal lactobacilli, L. 
bulgaricus does not encode mucin-binding proteins and it is deficient of bile salt hydrolase 
genes, properties important for survival and activity in the gastrointestinal tract 
(Klaenhammer et al., 2008). The bacterium has shown no adhesion to human intestinal 
cells in an in vitro system (Elo et al., 1991; Kleeman et al., 1998). However, regular 
yogurt consumption can be a contributing factor to the establishment and survival of L. 
bulgaricus in upper and lower gastrointestinal tract (Lick et al., 2001; Mater et al., 2005; 
Elli  et  al.,  2006;  Vieira  et  al.,  2008).  Additionally,  a  careful  setup  of  the  analytic  
procedures can improve the reliability of studies regarding the survival of yogurt starters 
as has been shown by Elli et al. (2006). The adhesion of some strains with known 
probiotic activity like Bifidobacterium lactis Bb12 can be significantly increased in the 
presence of L. delbrueckii subsp. bulgaricus when tested in vitro (Ouwehand et al., 2000) 
which, in the context of human microbiota, may highlight synergism among healthy 
bacteria. 
Evidence of plausible probiotic activity of yogurt starter bacteria has been accumulated 
predominantly from in vitro studies. The proposed mechanisms of probiotic activity of L. 
bulgaricus include: 1) antagonism with pathogens by competition for binding sites and/or 
inhibition of intracellular signaling pathways; 2) stimulation of the mucosal immune 
system and augmentation of the host defense against pathogenic bacteria and foreign 
antigens (Nagafuchi et al., 1999). 
L. bulgaricus probiotic activity can be ascribed to its ability to produce substances with 
antimicrobial properties. Lactobacilli are known to inhibit the growth of pathogenic 
bacteria, possibly by producing inhibitory compounds such as organic acids, hydrogen 
peroxide and bacteriocins (Jacobsen et al., 1999; Loessner et al., 2003). Bulgarican, 
lactobulgarican, lactobacillin EG4, lactacin A and B are bacteriocins defined in this 
species (Reddy et al., 1984; Abdel-Bar et al., 1987; Giraffa et al., 1989; Toba et al., 1991; 
Nettles and Barefoot, 1993). Evaluating the cultural conditions with respect to bacteriocin 
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production  Balasubramanyam and Varadaraj (1998) have shown that bacteriocin 
production is strain dependent and can occur from the logarithmic phase through the early 
stationary  phase  at  the  optimal  growth  temperature,  37  -  45°C  and  an  acidic  pH  range  
between 4.0 -5.0 (Reinheimer et al., 1990). Bacteriocins are proteinaceous in nature and 
stable at 75° C for 30 min. Their inhibition spectrum is narrower than that of antibiotics 
(McAuliffe et al., 2001; Morency et al., 2001) and their activity is mainly targeted against 
closely related species. A small (3.6-6 kDa) heat stable bacteriocin containing 29 amino 
acids from L. bulgaricus has shown inhibitory activity against Listeria monocytogenes, 
Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, Yersinia enterocolitica 
and Y. pseudotuberculosis (Miteva et al., 1998). In light of fermented food industry 
bacteriocin producing strains can be effectively used as food biopreservatives. On the 
other hand, the deleterious effect of pathogen byproducts on host cells may be diminished 
in the presence of L. bulgaricus. A bioactive component released by a L. bulgaricus LDB 
B-30892 was capable of inhibiting or deactivating the exotoxins released by C. difficile 
thus protecting Caco-2 cells from C. difficile-mediated cytotoxicity (Banerjee et al., 2009). 
Pretreatment with L. bulgaricus prior to infection with E. sakazaki, known for its ability to 
stimulate the production of NO leading to apoptosis of IEC-6 cells,  was effective in 
preserving enterocyte integrity both in vitro and in vivo (Hunter et al., 2009). Furthermore, 
viable L. bulgaricus cells can prevent TLR4 signaling activation and IL-8 production 
mediated by H.  pylori in vitro, thus attenuating pathogenic potential of the latter species 
(Zhou et al., 2008). 
However,  so  far  L. bulgaricus has not been studied with respect to the inhibition of 
common oral pathogens. 
Immunomodulatory activity has been assessed both in in vitro and in vivo experiments. 
The mucosal immune activation is an extremely important characteristic for the selection 
of probiotic bacteria (Dogi et al., 2008). Yogurt bacteria may potentiate the production and 
the release of IFN-? by immunocompetent cells and thereby modulate the host immune 
response (DeSimone et al., 1986; Makino et al., 2006). L. bulgaricus strains can induce 
cytokine (TNF-a, IL-6, IL-2, and IL-5) secretion in cultured macrophages and T-cells 
which play a central role in cell-mediated and humoral immunity (Marin et al., 1998). An 
immunostimulatory oligonucleotide sOL-LB17 found in L. delbrueckii supsp. bulgaricus 
strain NIAI B6 could substantially bind to B-cells increasing the number of CD69 positive 
cells in the Peyer`s patches (Kitazawa et al., 2003).   
Consumption of yogurt has been shown to induce measurable health benefits like 
strengthening of gut barrier function and prevention of intestinal infections; prevention of 
antibiotic-associated diarrhea and immunomodulation (Pereyra and Lemannier, 1993; 
Trapp et al., 1993; Meydani and Ha, 2000; Hickson et al., 2007; Zeng et al., 2008). 
Positive correlation has been observed in the presence of live bacteria when compared 
with products with heat-killed bacteria (Gilliland and Kim, 1984; Savaiano et al., 1984; 
Dewit et al., 1988; Lerebours et al., 1989; Van de Water et al., 1999; Rizkalla et al., 2000). 
Binding of free bile acids by cells of yogurt starter culture bacteria can even be considered 
as a favorable anti-hypocholesterolemic effect of these species (Pigeon et al., 2002). 
Moreover, radical scavengers produced in the culture of L. delbrueckii subsp. bulgaricus 
2038 may have a preventive effect on the oxidation of LDL (Terahara et al., 2000). 
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According to current scientific concepts, Guarner et al. (2005) have proposed yogurt 
starter cultures to be regarded probiotics if a beneficial physiological effect can be 
obtained by consumption of the live cultures and the benefit is substantiated appropriately 
in human studies. 
2.5 Issues of safety in the oral health perspective 
The growing market of functional foods and widespread use of probiotics has raised the 
question of their possible health risks. Although lactobacilli and bifidobacteria are 
ubiquitous in fermented dairy products and possess a GRAS status, there is always the 
danger that prolonged probiotic intake may cause bacteraemia or endocarditis, transfer 
antibiotic resistance, and to have detrimental metabolic effects in general (Marteau, 2002; 
Land et al., 2005; Snydman, 2008, Liong, 2008; Agostoni et al., 2008). However, results 
from clinical studies have demonstrated that probiotics are well tolerated by various 
patient groups (Millar et al., 1993; Majamaa and Isolauri, 1997; Pedone et al., 1999; 
Rosenfeldt et al., 2003; Viljanen et al., 2005) with only a few cases with clinically 
manifested side effects (Kirjavainen et al., 2003). Hammerman et al. (2006) have 
concluded that the benefits of probiotics outweigh their potential danger, but yet particular 
concern must be given to immunocompromised patients and patients with severe 
conditions (Salminen et al., 2004; Wada et al., 2009). In a randomized, placebo-controlled, 
cross-over study with human immunodeficiency virus patients probiotic use of L. 
rhamnosus GG was not found to alleviate gastrointestinal symproms or non-infections 
diarrhea, but was not associated with any adverse effects or infections and therefore can be 
regarded as safe (Saminen, 2006). 
Although probiotics have proven effective against caries pathogens lactobacilli themselves 
may associate with caries progression. Some strains of Lactobacillus spp., together with S. 
mutans have been implicated in caries development (Montalto et al., 2004). The 
production of organic acids from dietary sugars is a leading factor also in dentin caries 
progression (Bradshaw and Marsh, 1998). Metabolism and acid production by probiotic 
lactobacilli anticipated to exert their properties in the mouth should not favor caries 
induction. Adhesion of two probiotics L. casei Shirota and L. acidophilus in an artificial 
caries model have shown inconclusive results about the potential of those species in caries 
progression; lactobacilli counts were higher in distilled water than in dentin samples under 
the terms of the study (Lima et al., 2005). A probiotic L. salivarius LS 1952R 
administered to rats in five consecutive days possessed an inherent cariogenic activity 
after adherence to tooth surface and enhanced cariogenicity of S. mutans (Matsumoto et 
al., 2005). Reproducing oral biofilm model Pham et al. (2009) have observed that L. 
salivarius W24 could establish itself in the biofilm if added simultaneously with the 
inoculum and it could lower the pH of sucrose-exposed microbiota. These findings 
indicate that once established in oral microbiota in the presence of sucrose L. salivarius 
W24 might increase the cariogenic potential of the oral microbial community. 
Six commercially available lactobacilli, L. plantarum 299v, L. plantarum 931, L. 
rhamnosus GG, L. rhamnosus LB12, L. paracasei F19, and L. reuteri were assessed for 
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acid production from various sugars and sugar alcohols (Hedberg et al., 2008). Among 
them, L. plantarum strains had the highest activity fermenting glucose, fructose, lactose, 
sucrose, maltose, trehalose, and arabinose. Fermentation of glucose, fructose, mannitol, 
and trehalose by L. rhamnosus GG resulted in pH values between 5.2 and 6.8 following 
24h incubation. L. paracasei and L. plantarum displayed very slow fermentation and pH 
values reaching 5.2 – 6.8 after 72h incubation. The inability of L. rhamnosus strains, L. 
paracasei F19 and L. reuteri to ferment sucrose adds valuable information about relative 
safety of these probiotic strains in the caries-prophylactic perspective. Another study 
addressing sugar fermentation has shown a strain-dependent pH drop and the decrease was 
the fastest with glucose for all fourteen strains tested, thus highlighting the acidogenic 
potential of probiotics (Haukioja et al., 2008). Bearing in mind the life long tradition of 
fermented dairy food consumption without deleterious side effects it can be anticipated 
that probiotic administration in a milk product is safer than if given in juice without added 
calcium and phosphorus (Meurman, 2009). 
Probiotics – host tissues cross-talk is another aspect of concern. Epithelial cells play 
essential role in providing innate defense against microbial challenge through the 
production of antimicrobial molecules, as well as cytokines and chemokines necessary for 
leukocyte recruitment (Kagnoff and Eckmann, 1997). Studies in gastrointestinal tract have 
shown very low induction of pro-inflammatory cytokines after probiotic challenge (Ortiz-
Andrellucchi et al., 2009; Selvam et al., 2009; Wang et al., 2009). The reaction was 
markedly strain-dependent (Medina et al., 2007). A significant reduction of TNF-? and IL-
8 levels in gingival crevicular fluid has been observed after two weeks intake of a chewing 
gum  with Lactobacillus reuteri ATCC 55730 and ATCC PTA 5289 (Twetman et al., 
2009). Nonetheless, more specific studies are called for the evaluation of safety with the 
emergence of new probiotic candidates in the oral cavity. 
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3 Hypotheses and aims of the study 
The main objective of this thesis was to assess in vitro the yogurt starter bacterium L. 
delbrueckii subsp. bulgaricus for probiotic activity with relevance to the mouth. The final 
goal would be to evaluate its suitability for oral cavity applications. 
Our working hypothesis was that with the daily intake of yogurt starter L. delbrueckii 
subsp. bulgaricus some mechanisms in the development of dental caries and periodontal 
diseases are positively affected. 
The specific aims of the studies were to assess: 
1. the antimicrobial activity of L. delbrueckii subsp. bulgaricus strains against 
various oral pathogens (oral streptococci, Aggregatibacter 
actinomycetemcomitans, Porphyromonas gingivalis, Fusobacterium 
nucleatum); 
2. the ability of dairy L. delbrueckii subsp. bulgaricus strains to adhere to saliva-
coated surfaces and to evaluate whether this species might affect the adhesion 
of oral streptococci in vitro; 
3. the proteolytic activity on human gelatinases of L. delbrueckii subsp. 
bulgaricus strains isolated from yogurt, thus addressing the issue of safety 
which  is  a  prerequisite  for  further  research  on  the  role  of  this  species  on  oral  
health; 
4. the epithelial cell response after stimulation with L. delbrueckii subsp. 
bulgaricus and  the  interference  of  the  species  on  cytokine  response  provoked 
by P. gingivalis. 
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4 Materials and methods 
4.1 Bacterial strains and culture conditions 
4.1.1 Lactic acid bacteria 
Strains of lactic acid bacteria used in the studies and their culture conditions are listed in 
Table 5. L. delbrueckii subsp. bulgaricus strains were kindly provided by LB Lactis 
(Scientific-Applied Laboratory for Starter Cultures and Probiotic Products, Plovdiv, 
Bulgaria) culture collection in milk medium. They were subcultured in de Man, Rogosa 
and  Sharpe  (MRS)  broth  at  pH  6.4  at  37°C  in  5%  CO2 atmosphere  for  24  h.  The  
lactobacilli were verified by Gram staining and carbohydrate fermentation patterns (API 
50 CHL, BioMerieux®, Lyon, France). The strains were maintained as frozen stock in 
10% skim milk at -70°C between different studies. 
 
Table 5. Lactic acid bacteria used in the studies and their culture conditions 
Strain Origin Growth 
medium 
Atmosphere Incubation 
time 
 
Article 
 
L. bulgaricus 
LBL-12 
 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
 
MRS 
 
5% CO2 
 
O/N 
 
I, II, III 
L. bulgaricus 
LBL-22 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
MRS 5% CO2 O/N I, II, III 
L. bulgaricus 
LBL-6 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
MRS 5% CO2 O/N I, II, III 
L. bulgaricus 
LBL-83 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
MRS 5% CO2 O/N I, II, III, IV 
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L. bulgaricus 
LBL-9 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
MRS 5% CO2 O/N I, II, III 
L. bulgaricus 
LBL-11 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
MRS 5% CO2 O/N I, II, III, IV 
L. bulgaricus 
LBL-23 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
MRS 5% CO2 O/N I, II, III 
L. bulgaricus 
LBL-10 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
MRS 5% CO2 O/N I, II, IV 
L. bulgaricus 
LBL-13 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
MRS 5% CO2 O/N I, II 
L. bulgaricus 
LBL-42 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
MRS 5% CO2 O/N I, II, IV 
L. bulgaricus 
LBL-3 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
MRS 5% CO2 O/N II, IV 
L. bulgaricus 
LBL-20 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
MRS 5% CO2 O/N II, IV 
L. bulgaricus 
LBL-39 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
MRS 5% CO2 O/N II, IV 
L. bulgaricus 
LBL-43 
Laboratory 
collection, LB 
MRS 5% CO2 O/N II 
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Lactis, 
Bulgaria 
L. bulgaricus 
LBL-81 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
MRS 5% CO2 O/N II, IV 
L. bulgaricus 
LBL-80 
Laboratory 
collection, LB 
Lactis, 
Bulgaria 
MRS 5% CO2 O/N IV 
L. bulgaricus 
ATCC 11842 
Valio Ltd., 
Helsinki, 
Finland 
MRS 5% CO2 O/N I, III 
L rhamnosus 
GG ATCC 
53103 
Valio Ltd., 
Helsinki, 
Finland 
MRS 5% CO2 O/N I, II, IV 
L. rhamnosus 
Lc705 
Valio Ltd., 
Helsinki, 
Finland 
MRS 5% CO2 O/N I 
L. casei 921 
ATCC 344 
Valio Ltd., 
Helsinki, 
Finland 
MRS 5% CO2 O/N I 
L. casei Shirota Yakult, Tokyo, 
Japan 
MRS 5% CO2 O/N I 
Abbreviations: O/N: over-night (16-18h). 
4.1.2 Oral bacteria 
Oral bacteria used in studies I and II, their origin and growth media are listed in Table 6. 
Table 6. Oral bacteria used in the studies. 
Strain Origin Growth 
medium 
Atmosphere Incubation 
time 
 
Article 
S. constellatus ATCC 
27823 
ATCC BHI 5% CO2 24 h I 
S. intermedius ATCC ATCC BHI 5% CO2 24 h I 
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27335 
S. mitis ATCC 33399 ATCC BHI 5% CO2 24 h I 
S. mutans ATCC 25175 ATCC BHI 5% CO2 24 h I 
S. oralis ATCC 35037 ATCC BHI 5% CO2 24 h I 
S. sobrinus ATCC 
33478 
ATCC BHI 5% CO2 24 h I 
S. salivarius ATCC 
13419 
ATCC BHI 5% CO2 24 h I 
S. anginosus ATCC 
33397 
ATCC BHI 5% CO2 24 h I 
A. 
actinomycetemcomitans 
ATCC 29523 
ATCC TS 5% CO2 24 h I 
A. 
actinomycetemcomitans 
ATCC 43718 
ATCC TS 5% CO2 24 h I 
A. 
actinomycetemcomitans 
ATCC 33384 
ATCC TS 5% CO2 24 h I 
A. 
actinomycetemcomitans 
ATCC 37399 
ATCC TS 5% CO2 24 h I 
A. 
actinomycetemcomitans 
ATCC 381 
ATCC TS 5% CO2 24 h I 
A. 
actinomycetemcomitans 
F1000  
Clinical 
isolate 
TS 5% CO2 24 h I 
A. 
actinomycetemcomitans 
F 296 
Clinical 
isolate 
TS 5% CO2 24 h I 
A. 
actinomycetemcomitans 
F 731 
Clinical 
isolate 
TS 5% CO2 24 h I 
A. 
actinomycetemcomitans 
F 982 
Clinical 
isolate 
TS 5% CO2 24 h I 
F. nucleatum ATCC ATCC Brucella agar Anaerobic 72 h I 
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25586 
P. gingivalis Q 710 Clinical 
isolate 
Brucella agar Anaerobic 72 h I 
P. gingivalis Q 282 Clinical 
isolate 
Brucella agar Anaerobic 72 h I 
P. gingivalis Q 118 Clinical 
isolate 
Brucella agar Anaerobic 72 h I 
P. gingivalis Q 677 Clinical 
isolate 
Brucella agar Anaerobic 72 h I 
 
4.1.3 Cell cultures 
Human mucosal keratinocyte cell line Tuija was used in study IV. This cell line has been 
obtained from surgical gingival biopsies and cultured in serum-free low calcium 
Keratinocyte Basal Medium (KBM) (Salo et al., 1991) and thereafter underwent 
spontaneous immortalization due to transfection with human papilloma virus (Pirisi et al., 
1988). Tuija cells were grown in KGM 2 supplemented with 0.15mM CaCl2,  2 ml BPE-
15, 0.125 ng ml-1 epidermal growth factor, 5 µg ml-1 insulin, 0.33µg ml-1 hydrocortisone, 
10 µg ml-1 transferrin, and 0.39 µg ml-1 epinephrine, at 37°C and passages between 35-45 
were used in the study. For separate experiments, cells were seeded at a concentration of 2 
x 10 5 cells ml-1  in 24-well tissue culture plates (Nunc, Roskilde, Denmark), and grown at 
37°C  in 5% CO2 until forming a monolayer with approximately 85% confluence. 
4.2 Methods 
Methods used in the separate studies are listed in Table 7 and described in detail in the 
original articles. 
 
Table 7. Methods used in studies I – IV. 
Method Described and used in 
Agar-overlay inhibitory assay I 
Streak-line inhibitory test I 
Quantitative assessment of adhesion of radiolabeled 
bacteria to saliva-coated surfaces 
II 
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Western blotting III 
SDS-PAGE III 
ELISA IV 
4.3 Study design 
4.3.1 Antimicrobial activity against various oral pathogens (I) 
To study the inhibitory activity of lactobacilli against renowned and putative oral 
pathogens (strains listed in Table 6) the agar overlay and streak line inhibitory assays were 
used dependent on the target bacteria. 
Agar overlay method as described by Kakessy and Piguet (1970) was used to 
determine the inhibitory activity of lactobacilli against oral streptococci and A. 
actinomycetemcomitans. The inhibition zones were measured after incubation for 24 h at 
37°C in 5% CO2. To measure the inhibitory activity the following formula (Coeuret et al., 
2004) was used: 
                           
Where, ID is the diameter of the inhibition halo, CD is the diameter of the colony. 
Scores below 0.5 are defined as slight inhibitory activity, between 0.5 and 1.5 as 
intermediate, and scores above 1.5 represent strong inhibition. 
Streak-line inhibitory activity test was performed according to Annuk et al. (2003) to 
study the inhibitory activity of lactobacilli against P. gingivalis and F. nucleatum strains. 
After 72 h incubation the width of the zone of inhibition (mm) extending from the target 
bacteria to the lactobacilli streak line was measured (Mikelsaar et al., 1987). 
4.3.2 Adhesion to saliva-coated surfaces in vitro (II) 
For adhesion studies the bacteria (listed in Table 5) were radiolabeled by growing the cells 
in appropriate broth supplemented with 10 ?l/ml of [methyl-1,2-3H]thymidine, 122 
Ci/mmol  (GE  Healthcare,  Chalfont   St  Giles,  Buckinghamshire,  UK)  as  previously  
described (Fernandez et al., 2003). 
Unstimulated whole saliva was collected from five healthy individuals who were 
instructed not to eat, drink, smoke, or use chewing gum for an hour before the saliva 
collection. Informed consent was obtained before the collection began. The saliva was 
collected into chilled tubes on ice and clarified by centrifugation (14,000 g for 20 min at 
4°C). The pooled samples were divided into aliquots and frozen at -20°C before the 
adhesion assays. 
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4.3.2.1 Adhesion to sHA beads 
Spheroid HA beads (Macro-Prep Ceramic Hydroxyapatite TYPE II 80 µm, Bio-Rad 
Laboratories, Hercules, CA) were equilibrated for 2 h in buffered KCl (0.05 m KCl 
containing 1 mm KH2PO4, 1mm CaCl2 and 0.1 mm MgCl2 at pH 6.5). 100 ?l saliva was 
added per well and the mixture was incubated for 1 h at 37°C. After three washings with 
buffered KCl (200 ?l/well) 100 ?l radioactive bacterial suspension was added to each well 
and incubated with shaking (50 r.p.m.) for 1 h. The radioactivity was measured by liquid 
scintillation counter (Winspectral 1414, Wallac, Turku, Finland). The adhesion ratio (%) 
of bacteria was calculated by comparing the radioactivity of the adhered bacteria to the 
radioactivity of the added bacteria. 
4.3.2.2 Adhesion to saliva-coated microtiter plates 
Adhesion to human saliva was assessed according to the method studying adhesion to 
intestinal mucus as described earlier by Ouwehand et al., (2001). Saliva was immobilized 
passively overnight at 4°C in 96-well polystyrene microtiter plates (Maxisorp, Nunc, 
Roskilde, Denmark; 100 ?l/well). Bacterial suspensions were added (100 ?l/well) and 
bacteria were allowed to adhere at 37°C for 1 h. Lactobacilli pretreated with lysozyme 
(0.05 mg/ml in phosphate-buffered saline (PBS), pH 6.2) were assessed for their ability to 
adhere to saliva. 
4.3.2.3 Adhesion to solvents 
Microbial adhesion to n-hexadecane was measured according to the method of Rosenberg 
et al. (1980). A detailed description of the method is given in study III. 
4.3.2.4 Effect of lactobacilli pretreatment on streptococcal adhesion in vitro 
To  study  the  effect  on  adhesion  of  S. sanguinis ATCC 10556 after Lactobacillus 
pretreatment of saliva-coated MaxiSorp plates, non-radiolabeled L. delbrueckii  subsp. 
bulgaricus strains were allowed to adhere to immobilized saliva for 1 h at 37°C. After two 
washes with HEPES–Hanks’ buffer, 100 ?l streptococcal suspension was added per well 
and incubated for 1 h at 37°C and the adhesion experiment was performed as already 
described. 
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4.3.3 Proteolytic activity on human gelatinases (III) 
The proteolytic activity of different L. bulgaricus strains (listed in Table 5) on human 
progelatinase B (pro-MMP-9) was evaluated based on a protocol used for assessing the 
gelatinolytic activity of defined oral pathogens (Grayson et al., 2003). 
Lactobacilli were grown in de Man, Rogosa and Sharpe broth at pH 6.4 (MRS broth, 
LAB  MTM,  IDG  Ltd.,  Lankashire,  UK)  at  37°C  in  5%  CO2 atmosphere. Cells were 
harvested by centrifugation at 5 000 g for 20 min, and the supernatants were dialyzed 
against  distilled  water  for  2  h  at  4°C.  Harvested  cells  were  washed  twice  with  PBS,  pH 
7.4, suspended in 1 mL of PBS. Prior to use they were sonicated on ice to disrupt the cells. 
Both cell fractions and the supernatant fractions were used in this study. 
The presence of gelatinolytic proteases was assayed with the use of an enzymography 
in 0.75-mm-thick 11% SDS-PAGE gels impregnated with 1 mg mL-1 gelatin, as described 
in Study III. White zones of lysis indicating gelatine degradation were revealed by 
staining with 1% Coomassie Brilliant Blue.  
The molecular forms of MMP-9 were detected by a modified (Sorsa et al., 1997) ECL 
Western blotting kit according to protocol recommended by the manufacturer (GE 
Healthcare, Amersham, UK). 
To determine the inhibitory effect of different synthetic MMP inhibitors on L. 
bulgaricus proteases, Ilomastat (Chemicon International Inc., CA, USA), EDTA (Merck, 
KGaA, Dramstadt, Germany), CMT3, CMT308 (Collagenex Inc., Newton, PA, USA), 
CTT1 (Koivunen et al., 1997) and a serine protease inhibitor, Pefabloc (Boehringer 
Mannheim GmbH, Manheim, Germany), were employed in this study. The MDPF-
zymography was assayed as previously to detect the residual gelatinolytic activity. 
4.3.4 Epithelial cell response to L. delbrueckii subsp. bulgaricus 
4.3.4.1 Induction of IL-8 and TNF-? secretion 
Lactobacilli in KGM 2 or culture supernatants (1 ml) were added to the epithelial cell 
monolayers and incubated for 6h and 24h at 37°C in 5% CO2. KGM 2 alone served as a 
negative control. At each time point 500µl of the cell culture medium was removed and 
centrifuged to obtain debris-free supernatant. Collected supernatants were stored at -20°C 
until ELISA assessment. 
4.3.4.2 Epithelial cell response to P. gingivalis after lactobacilli pretreatment 
After 24h incubation with lactobacilli the epithelial cells were washed twice with PBS and 
P. gingivalis in KGM 2 was added to a volume of 1 ml to each well.  The epithelial  cell  
monolayers were then cultured at 37°C in 5% CO2. After 1, 2 and 24h 500µl supernatants 
were collected for ELISA analyses. 
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4.4 Statistical analyses 
All experiments were run at least in duplicate and scores are presented as means ± SEM. 
Differences were considered significant when P<0.05. Appropriate parametric and non-
parametric tests employed are described in detail in studies I-IV. 
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5 Results and discussion 
The present series of studies addressed several key aspects of probiotic activity to be 
assessed with respect to possible oral cavity applications. 
5.1 Inhibition of oral pathogens (Study I) 
Thirty lactobacilli strains, 11 of which were L. bulgaricus, were assessed for their 
inhibitory activity against 23 strains of oral pathogens.  
A. actinomycetemcomitans strains were the most susceptible to the inhibitory activity 
of the lactobacilli tested. The inhibition varied significantly from slight to strong (p<0.05). 
Four L. bulgaricus strains, namely L. bulgaricus LBL-9, L. bulgaricus LBL-11, L. 
bulgaricus LBL-23, and L. bulgaricus LBL-83, showed the most pronounced inhibitory 
activity among all strains tested (EIR>2). No difference was observed in growth inhibition 
between the clinical isolates of A. actinomycetemcomitans vs. commercial strains. Table 8 
presents the inhibitory activity of L. bulgaricus strains against A. actinomycetemcomitans. 
Our results are in agreement with the results by Koll-Klais et al., (2005) who reported that 
homo-fermentative lactobacilli expressed significant antimicrobial activity against 
periodontal pathogens. L. bulgaricus is an obligate homofermentative and most of the 
strains strongly inhibited A. actinomycetemcomitans. 
 
Table 8. Inhibition of clinical and commercial isolates of A. actinomycetemcomitans by L. 
delbrueckii subsp. bulgaricus strains tested. 
Strain Aggregatibacter actinomycetemcomitans 
 
ATTC 
29523 
 
ATCC 
43718 
 
ATCC 
33384 
 
ATCC 
37399 
 
ATCC 
381 
 
F 
1000 
 
F 
296 
 
F 
731 
 
F 
982 
 
Mean 
±SD 
L. 
bulgaricus 
365 
2.4 1.4 1.2 1.9 1.3 1.3 1.8 1.8 1.5 1.6±0.3 
L. 
bulgaricus 
LBL-23 
2.2 2.8 3.2 2.4 1.4 1.5 2 1.5 2.1 2.1± 0.5 
L. 
bulgaricus 
LBL-12 
2.9 0.8 0.8 1.2 1.1 0.9 1.4 1.1 1.3 1.6± 1.6 
L. 0 0 0 0 0.5 0 1.3 0.1 0.6 0.3± 0.4 
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bulgaricus 
LBL-22 
L. 
bulgaricus 
LBL-6 
3.2 0 0 0 0 0.3 0 0.6 1.1 0.6±0.0
5 
L. 
bulgaricus 
LBL-10 
2.2 2.3 2.8 2.5 0.9 2.5 1.1 1.9 2.9 2.1±0.7 
L. 
bulgaricus 
LBL-13 
0.5 3 2.3 1.7 0 1 1.3 1.2 0.7 1.3±0.9 
L. 
bulgaricus 
LBL-83 
4 4.5 3.8 2.1 1.3 1.1 1.1 2.5 2.2 2.5±1.3 
L. 
bulgaricus 
LBL-42 
1.6 4.2 2.2 2.1 1.7 1.6 2.1 1.2 2 2± 0.8 
L. 
bulgaricus 
LBL-9 
2.2 3.8 3.5 3.3 2 1.3 2.4 1.3 2.2 2.4±0.9 
L. 
bulgaricus 
LBL-11 
3.5 2.8 3.7 4.4 1.5 1.6 1.8 1.8 1.6 2.5±1.1 
 
Oral streptococci showed various patterns of susceptibility to lactobacilli. In general the 
average inhibitory activity of lactobacilli against streptococcal species was low (EIR = 
0.5). Among the lactobacilli tested only strains of L. bulgaricus inhibited  the  growth  of  
oral streptococci. The pattern of inhibitory activity of L. bulgaricus strains against 
streptococcal species is given in Figure  2. In the present study S. mutans was strongly 
inhibited by single L. bulgaricus strains  (L. bulgaricus LBL-23 being the strongest). 
Strahinic et al. (2007) and Koll-Klais et al. (2005) have shown that S. mutans is 
susceptible to growth inhibition by various oral lactobacilli. Considering the common use 
of yogurt in the diet of many populations dairy strains may indeed affect the composition 
of oral biofilm formation already in early childhood if the dairy starter bacteria interact 
with commensal microflora, thus altering its cariogenic potential. 
 
48
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
 LBL-23  LBL-22  LBL-6  LBL-10  LBL-13  LBL-83  LBL-42  LBL-9  LBL-11
L. bulgaricus strains
Ef
fe
ct
iv
e
in
hi
bi
to
ry
ra
tio
S. oralis
S.mutans
S. sobrinus
S. mitis
S. constellatus
S. intetrmedius
S. salivarius
S. anginos
Figure 2. Effective inhibition ratio against oral streptococci by L. bulgaricus.
The mechanisms by which L. bulgaricus strains inhibited oral pathogen growth are not
fully understood. Lactobacilli may exert their antibacterial activity through the production
of organic acids (lactic and acetic acid) and other metabolites such as hydrogen peroxide
and diacetyl, or specific bactericidal or bacteriostatic peptides and proteins (De Vuyst et
al., 1994). We observed that when lactobacilli were grown on MRS agar with normal
glucose content, instead of 0.2% glucose agar, growth inhibition of both the streptococci
and A. actinomycetemcomitans was more pronounced. Koll-Klais et al. (2005) reported the
same which indicates that the availability of substrate for fermentation seems to be one of
the essential factors for the antimicrobial activity. We have found that culture supernatants
of lactobacilli possessed no antimicrobial activity against streptococci and A.
actinomycetemcomitans when using the well-diffusion or paper-disk assays according to
Drago et al., (1997). Hence, the inhibitory mechanisms may be cell bound functions.
Streak line inhibition test used to study the effect of lactobacilli against P. gingivalis
and F. nucleatum showed low susceptibility of these bacteria. There was no inhibitory
activity observed among L. bulgaricus strains against either P. gingivalis or F. nucleatum.
The inhibitory pattern varied distinctly between the lactobacilli tested. However, there
was no single Lactobacillus strain to demonstrate growth inhibition against all four oral
pathogen species used. Thus, no single Lactobacillus species can be used in combating
oral pathogens in broader sense and several species need to be considered when selecting
“oral probiotics”.
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5.2 L. bulgaricus adhesion to saliva-coated surfaces (Study II) 
Adhesion of bacteria to host surfaces is regarded of major importance in contributing to 
permanent, or even transient, establishment of probiotic species in any environmental 
niche. In the present study we focused on the bacterial adhesion to human saliva that is the 
main fluid overlying oral surfaces. Presumably probiotic bacteria that express good 
binding ability to salivary pellicle may also be able to colonize the oral cavity. 
Saliva-coated HA beads have been commonly used as an in vitro model to 
quantitatively study adhesion of radiolabeled bacteria because the surface properties are 
similar to those of tooth enamel (Gibbons et al., 1982). Adhesion to sHA varied between 1 
to 17%, and L. bulgaricus LBL-39 exhibiting values comparable to that of the reference 
strains S. sangunis. S. sanguinis is  the  first  colonizer  on  tooth  surfaces  in vivo and its 
ability to adhere to sHA make it a suitable model for dental adhesion studies.  
Generally, the adhesion of most L. delbrueckii subsp. bulgaricus strains to sHA was 
low (<5%) under the present experimental conditions. The adhesion to saliva-coated 
Maxisorp plates ranged between 3 and 22%, with LBL-39 exhibiting the strongest ability 
to adhere.  
A significant increase in the adhesive properties was observed when the strains were 
pretreated with lysozyme (P < 0.05); results are shown in Figure 3. 
                 
 
 
Figure 3. Adhesion of L. bulgaricus to saliva-coated Maxisorp plates after lysozyme 
pretreatment. 
Tellefson and Germaine (1986) have found that lysozyme promoted the adherence of 
some oral streptococci (S. sanguinis)  to  sHA.  The  role  of  lysozyme  pretreatment  on  
probiotic properties has recently been also addressed as a factor improving the 
immunostimulatory effect of probiotic species (Bu et al., 2006). 
Cell surface hydrophobicity has been considered a valuable reference when evaluating 
the adhesive properties of microorganisms. High hydrophobicity correlated with marked 
adhesion (Wadström et al., 1987). The assessment of cell surface hydrophobicity might be 
used as a test for studying adhesive properties of bacteria because this characteristic has 
been reported to objectively reflect microbial adhesion (Ellepola et al., 2001; Wadström et 
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al., 1987). By measuring adhesion to n-hexadecane we observed that the strains 
investigated showed various patterns of interaction with the organic solvent, as shown in 
Figure  4. The Lactobacillus strain LBL-39 which had shown the most pronounced 
adhesive properties to saliva-coated surfaces again displayed the strongest adhesive 
potential. 
         
 
 
                        Figure 4. Adhesion of L. bulgaricus to n-hexadecane. 
As S. sanguinis and lactobacilli were able to adhere to saliva-coated surfaces we 
hypothesized that these two species may compete when present together. However, the 
adhesion of S. sanguinis ATCC 10556 was not significantly affected by the pretreatment 
of the wells with any of the Lactobacillus strains, as shown in Figure 5. 
 
 
                     Figure 5. Adhesion of S. sanguinis ATCC 10556 to saliva-coated microtiter plates 
after pretreatment with the lactobacilli studied. 
The competitive inhibition for bacterial adhesion sites has been considered as a favorable 
mechanism for probiotic action (Fernandez et al., 2003). Despite the fact that lactobacilli 
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adhered to various extents to the immobilized saliva they were not able to affect the 
adhesion of the target microorganism tested. It could therefore be concluded that the 
salivary receptors are different for dairy strains and S. sanguinis and that pretreatment with 
lactobacilli does not block streptococcal adhesion by steric hindrance. Similar results were 
observed for other probiotic species that also lacked the capacity to change the adhesive 
potential of several skin pathogens (Ouwehand et al., 2003). 
Issues of safety demand substantial consideration and in vitro tests are critical when 
assessing the mechanisms of probiotic effect with no hazards being imposed on the host 
by the use of living microorganisms in therapy. Safety issues of lactobacilli have been 
studied by evaluating adhesion to main constituents of extracellular matrix: collagen type 
IV and fibrinogen; binding to intestinal mucus; induction of respiratory burst in peripheral 
blood monocytes and resistance to serum-mediated killing (Vesterlund et al., 2007). There 
were no studies addressing the issues of safety related to screening of putative probiotic 
species with the scope of application in the oral cavity. A favorable metabolic activity and 
harmless host-bacteria interactions that pose no risk to oral health of the individual must 
be considered when putative probiotics are administered in the mouth. L. delbrueckii 
subsp. bulgaricus that is essential in yogurt production exerts high hydrolysing activities 
towards substrates containing proline, alanylprolyl–p–nitroanilide and prolyl–p–
nitroanilide (Sasaki et al., 1995). It is known that L. delbrueckii subsp. bulgaricus 
possesses  a  complex  proteolytic  system  essential  for  rapid  growth  in  protein-rich  media  
(Atlan et al., 1994) and the hydrolysis of milk caseins by means of a cell-wall proteinases 
has been extensively studied (Smid et al., 1991; Laloi et al., 1991). A cell-envelope-
associated aminopeptidase characterized as metallo-enzyme with a broad specificity has 
been purified from the cell wall of L. bulgaricus, L. lactis, and L. helveticus (Atlan et al., 
1989; Blanc et al., 1993). 
5.3 Proteolytic activity on human progelatinase B (proMMP-9) 
(Study III) 
In the present study we applied a method evaluating the effect of probiotic candidates on 
the activation of matrixmetalloproteinases (MMPs), the enzymes responsible for 
extracellular matrix degradation and remodeling. Elevated levels of salivary MMPs have 
been associated with metabolic activity of various oral pathogens (Ding et al., 1997; 
Mäntylä et al., 2003; Söder et al., 2006). Thus, the capacity of some microbial species to 
convert extracellular matrix enzymes into their active forms might be considered an 
inherent virulence factor. 
5.3.1 Gelatinolytic activity 
Gelatin  zymography  with  labeled  substrate  enables  the  detection  of  type  I  and  type  IV  
collagenolytic activity. The gelatinolytic activity of all strains tested was very low 
compared with positive human saliva controls. Degradation of gelatin was not detected 
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after an 18 h incubation period. However, the prolonged 7-day incubation time yielded 
molecular weight bands at the area of 106 kDa and around 150 kDa (Figure 6). There was 
no significant difference in the gelatinolytic activity when the different pH values of the 
buffers were used. Supernatant samples, although showing only weak proteolytic activity, 
were more potent in degrading gelatin than the cell fraction samples which yielded no 
visible bands on the UV light picture. No difference was observed among the strains in the 
degradation of gelatin. 
 
 
 Figure 6. Gelatinolytic activity of L. delbrueckii subsp. bulgaricus supernatants. All 
strains show similar bands of activity after a 7-day incubation period. 
Considering the attachment to oral mucosa, it is essential that the microorganism is not 
harmful to mucosal cells and extracellular matrix and basement membrane components. A 
damaged or disintegrated oral epithelium facilitates a microbial invasion, providing 
appropriate environment for further bacterial growth. Most bacterial proteinases, however, 
have weak degrading activity against collagen (Okamoto et al., 2004). Once activated 
human collagenolytic MMPs might provide suitable substrate for further activity of human 
gelatinases or other bacterial proteinases. The test strains investigated in our study 
demonstrated very low gelatinolytic activity even after the longest incubation period, 
which validates their relative safety as probiotic candidates. 
5.3.2 Activation of proMMP-9 
ProMMP-9 was incubated for three different time periods with supernatants and cell 
fraction suspensions of the L. bulgaricus strains.  The  conversion  of  proMMP-9  into  its  
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active form was not detected after 24h of incubation as shown by Western blotting with 
the anti-MMP-9 antibodies (Figure 7A and 7B). 
 
 
 
 
 Figure 7. L. delbrueckii subsp. bulgaricus strains are ineffective in converting 
proMMP-9 to its active form as shown on Western blotting images. A. Supernatant fractions; B. 
Cell fractions. 
MMPs are expressed at low levels in the absence of inflammation, wound healing or other 
pathological processes (Woessner, 1991).  
MMP-9 and other endogenous proteinases hydrolyze and degrade the fragments of 
denatured collagens, for example gelatin, into smaller fragments. It has been shown in 
many studies that MMP-9 is a specific marker for periodontal destruction (Ejeil et al., 
2003) and elevated levels of this enzyme are related to the severity of periodontal 
breakdown. Referred to as type IV collagenase MMP-9 is particularly implicated in the 
degradation of the basement membrane (Reynolds and Meikle, 1997). The proteolysis of 
the ECM seems to play an important role in initiating the progression of the inflammatory 
process,  and  thus  conversion  of  proMMPs  into  their  active  forms  is  a  crucial  step  here,  
facilitating bacterial adhesion and infection. Studies on the activation of human MMPs 
have shown that some bacterial species with clear pathogenic potential are capable of 
activation of MMPs. For example, Vibrio proteinase and Pseudomonas elastase have 
shown stronger activation of pro-MMP-9 than did APMA (Okamoto et al., 1997). 
Furthermore, pro-MMPs can be activated by a variety of mechanisms that include 
proteinases such as plasmin; thiol-oxidizing agents, e.g., HgCl2 and N-ethylmaleimide; 
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low pH; and heat treatment (Vise and Nagase, 2003). MMPs are secreted as proenzymes 
and their activity is low in intact normal tissues but could undergo activation by a broad 
range of stimuli (Sorsa et al., 1997; Johnson et al., 1998; Potempa et al., 2000; Okamoto et 
al.,  2004).  A  key  event  in  the  activation  of  proMMPs  is  the  removal  of  the  propeptide  
domain in their structure that usually consists of ca. 80 amino acid residues (Nagase et al., 
1990). Lactobacillus bulgaricus strains in our study were incapable in converting the 
proMMP-9 to the 60–80 kDa forms considered active and did not show any activity at the 
region of the molecular mass consistent with protease IV. 
5.3.2 Proteolytic activity of L. bulgaricus strains in the presence of 
synthetic MMP inhibitors 
To investigate if the synthetic inhibitors of MMPs affect the gelatinolytic activity of 
bacterial proteases, the L. bulgaricus strains tested were incubated with five different 
synthetic MMP inhibitors and Pefabloc. No significant changes in gelatinolytic activity 
were observed on Coomassie Brilliant Bule stained gels. Synthetic MMP inhibitors and 
Pefabloc did not affect the proteolytic activity of the supernatants or the cell fraction 
suspensions of the L. bulgaricus strains investigated. 
The administration of synthetic inhibitors of MMPs is considered a therapeutic 
approach in the treatment of different pathological conditions in which elevated levels of 
MMPs are regarded as key factors in inflammation and tissue breakdown. The preserved 
and unaffected proteolytic activity of the test strains after addition of different synthetic 
MMP inhibitors and Pefabloc in the test system might additionally benefit the anticipated 
probiotic effect of those microorganisms. Consequently, a simultaneous administration of 
potential probiotics and inhibitors of MMPs should not be regarded contradictory when 
potential new treatment modes for infectious diseases are being considered. 
5.4 Epithelial cell – lactobacilli interactions (Study IV) 
In vitro experiments as conducted here are the first step in the evaluation of safety aspects 
when the oral cavity is exposed to high numbers of lactobacilli. The integrity of the 
epithelial lining of the oral cavity is part of the innate defense and serves as an effective 
barrier against various microorganisms. 
The ability of oral epithelial cells to secrete proinflammatory cytokines, IL-8 and TNF-
?, in response to five different lactobacilli species at two different concentrations, 106 
CFU ml-1 and 109 CFU ml-1, was examined. The viability of cultured epithelial cells 
remained above 85% during the whole set of experiments. 
In the present study the strongest induction of IL-8 secretion was observed with live 
bacterial samples at the higher concentration (109 CFU ml-1) compared to heat killed 
bacteria (p < 0.05). The increased levels of IL-8 were concentration dependent. Heat killed 
bacterial samples at concentration of 106 CFU ml-1 were stronger inducers of IL-8 than 
heat killed bacteria at 109 CFU ml-1 (p < 0.05). One strain, namely L. bulgaricus LB-86, 
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induced significantly lower secretion of IL-8 compared with A. actinomycetemcomitans 
positive controls (p < 0.05). The remaining strains within this group showed IL-8 values 
similar to those measured for A. actinomycetemcomitans at the 6h incubation-point. Heat 
killed L. bulgaricus LB-39, L. bulgaricus LB-3, L. bulgaricus LB-11, L. bulgaricus LB-
42, L. bulgaricus LB-86 induced significantly higher levels of IL-8 compared to their live 
counterparts 6h after co-culturing with the epithelial cells. Figure 8 shows the dynamics 
of IL-8 secretion within 24h of co-culturing of lactobacilli with the epithelial cells. 
Bacterial culture supernatants of all the strains tested led to undetectable levels of IL-8 in 
the culture medium. Furthermore, the addition of P. gingivalis to the epithelial cells 
pretreated with lactobacilli showed an almost immediate disappearance of any detectable 
levels of IL-8 in culture medium. 
 
 Figure 8. Levels of IL-8 secreted after co-culturing of oral epithelial cells with heat 
killed and live lactobacilli strains at two different concentrations ( OD = 0.1 and OD = 0.5, 
corresponding to 106 and 109 CFU ml-1). Supernatants were collected at 6 and 24h. 
After co-culturing with lactobacilli the epithelial cells responded with different 
concentrations of TNF-? secreted in the culture medium. Generally, the concentration of 
TNF-? was low in most cases. Bacterial culture supernatants were unable to stimulate 
cytokine secretion. The higher bacterial concentrations (109 CFU ml-1) led to a significant 
difference between the live and heat killed bacteria (p <0.05). L. bulgaricus LB-39 
induced a significant increase of TNF-?, whereas seven L. bulgaricus strains produced no 
effect. The addition of P. gingivalis led to a significant increase in TNF-? in the culture 
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medium and the concentration increased during the first 2 hours of incubation, whereas at 
the end of the experiment the detected values were lower. When the epithelial cells were 
pretreated with lactobacilli prior to the P. gingivalis addition the concentration of secreted 
TNF-? was lower than when P. gingivalis was added alone to the cells maintained in the 
culture medium.  
Hence in our present study we analyzed the secretion of two common proinflammatory 
cytokines that are generally associated with inflammation. Cytokines are secreted proteins 
that are responsible for many of the cellular responses of the innate and adaptive 
immunity,  and  thus  function  as  the  "messenger  molecules"  of  the  immune  system.  IL-8  
and TNF-? are released by the oral epithelium in response to fungal or bacterial infection 
and they trigger further cellular responses. Cytokine expression induced by lactobacilli at 
various mucosal sites has been investigated in animals, human biopsy specimens, as well 
as in monolayer cell culture models. The inhibition of secretion of IL-4, IL-5, and IL-8 has 
been defined as a property of many strains of lactobacilli (Carbo et al., 2002; Pochard et 
al., 2002). However, the oral epithelium has not yet been investigated regarding cytokine 
expression after probiotic challenge. Because of the emerging concern of probiotic safety, 
especially in cases with immunocompromised patients, the results obtained by us merit 
particular interest. It is noteworthy to point out that probiotic properties do not always 
require administration of live bacteria. Additionally, fermented dairy products are 
common vehicles for probiotics and the oral cavity obviously serves as the first site where 
these bacteria can exert their effects. Subsequently our results provide further evidence 
showing that higher doses of live probiotic or putative probiotic species may induce IL-8 
secretion similar to what was observed with the periodontal pathogen A. 
actinomycetemcomitans.  
By including P. gingivalis in the study we investigated whether probiotic interaction 
with the epithelial cells affects further cell response caused by the P. gingivalis. This 
organism is an established periodontal pathogen that in addition to its large array of 
virulence factors inducing periodontal tissue damage may also possess a variety of evasion 
mechanisms towards host defense. Among others these may lead to altered 
polymorphonuclear cell (PMN) function and impaired immune response in general. We 
have demonstrated here that the epithelial cells pretreated with lactobacilli produced 
pronounced levels of IL-8, shortly after the addition of P. gingivalis suspensions and also 
displayed absence of IL-8 in the cell culture supernatant. This phenomenon could be 
attributed to the high proteolytic activity of P. gingivalis which causes degradation of 
cytokines and chemokines (Calkins et al., 1998; Banbula et al., 1999; Bodet et al., 2005). 
A strain dependent pattern on TNF-? secretion after P. gingivalis challenge was also 
observed. The strongest inducer of TNF-? among the L. bulgaricus strains, LB-39, led to 
significantly lower levels of TNF-? after incubation with P. gingivalis. Attenuated 
expression, but not absence of TNF-? after the P. gingivalis infection, was observed with 
another L. bulgaricus strain, namely LB-80. On the other hand, pretreatment of the 
epithelial cells with heat killed L. bulgaricus LB-42 led to six fold increase in TNF-? 
concentrations after P. gingivalis challenge. These results provide evidence to the complex 
mechanisms of interaction between lactobacilli and epithelial cells and warrant further 
investigations. 
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6 Key findings and conclusions 
These series of studies addressed some key characteristics for the evaluation of probiotic 
properties of L. delbrueckii subsp. bulgaricus with  respect  to  the  oral  cavity.  The  main  
findings can be summarised as follows: 
 
1. Among L. delbrueckii subsp. bulgaricus species there are strains capable of 
inhibiting growth of some key oral pathogens, S. mutans and A. 
actinomycetemcomitans being the most susceptible to the inhibitory effect. 
2. The adhesive properties of yogurt starter L. delbrueckii subsp. bulgaricus to 
saliva-coated surface are comparatively low although single strains 
demonstrated adhesive potential similar to that of strongly adhering reference 
species. 
3. L. delbrueckii subsp. bulgaricus strains  are  harmless  to  main  components  of  
extracellular matrix, being unable to convert proMMP-9 to its active form, thus 
highlighting their safety on regulatory enzymes and structures of the host 
extracellular matrix. 
4. L. delbrueckii subsp. bulgaricus can induce IL-8 and TNF-? after stimulation of 
oral epithelial cells in vitro which is strain and concentration dependent. The 
addition of P. gingivalis to epithelial cells pretreated with lactobacilli led to 
pronounced reduction of cytokine levels in cell culture supernatants probably 
due to its high proteolytic activity. 
 
Based on the results of this research it is suggested that among the L. delbrueckii subsp. 
bulgaricus species  there  are  strains  that  could  be  further  studied  as  probiotics  with  
eventual health promoting effects in the oral cavity. Furthermore, a combination of several 
strains with favorable properties merits further investigation in the oral health perspective. 
However, more research is needed to optimize the selection of proper strain/s to be used as 
oral probiotics and to decide the best and appropriate means for probiotic administration 
into the mouth.  Phase I, II, III, and IV clinical trials need then to be conducted. 
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